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Résumé 
La famille des gènes Hox code pour des facteurs de transcription connus pour leur 
contribution essentielle à l’élaboration de l’architecture du corps et ce, au sein de tout le 
règne animal. Au cours de l’évolution chez les vertébrés, les gènes Hox ont été redéfinis 
pour générer toute une variété de nouveaux tissus/organes. Souvent, cette diversification 
s’est effectuée via des changements quant au contrôle transcriptionnel des gènes Hox.  
Chez les mammifères, la fonction de Hoxa13 n’est pas restreinte qu’à l’embryon même, 
mais s’avère également essentielle pour le développement de la vascularisation fœtale au 
sein du labyrinthe placentaire, suggérant ainsi que sa fonction au sein de cette structure 
aurait accompagné l’émergence des espèces placentaires.  
Au chapitre 2, nous mettons en lumière le recrutement de deux autres gènes Hoxa, soient 
Hoxa10 et Hoxa11, au compartiment extra-embryonnaire. Nous démontrons que 
l’expression de Hoxa10, Hoxa11 et Hoxa13 est requise au sein de l’allantoïde, précurseur 
du cordon ombilical et du système vasculaire fœtal au sein du labyrinthe placentaire. De 
façon intéressante, nous avons découvert que l’expression des gènes Hoxa10-13 dans 
l’allantoïde n’est pas restreinte qu’aux mammifères placentaires, mais est également 
présente chez un vertébré non-placentaire, indiquant que le recrutement des ces gènes dans 
l’allantoïde précède fort probablement l’émergence des espèces placentaires. Nous avons 
généré des réarrangements génétiques et utilisé des essais transgéniques pour étudier les 
mécanismes régulant l’expression des gènes Hoxa dans l’allantoïde. Nous avons identifié 
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un fragment intergénique de 50 kb capable d’induire l’expression d’un gène rapporteur 
dans l’allantoïde. Cependant, nous avons trouvé que le mécanisme de régulation contrôlant 
l’expression du gène Hoxa au sein du compartiment extra-embryonnaire est fort complexe 
et repose sur plus qu’un seul élément cis-régulateur. 
Au chapitre 3, nous avons utilisé la cartographie génétique du destin cellulaire pour évaluer 
la contribution globale des cellules exprimant Hoxa13 aux différentes structures 
embryonnaires. Plus particulièrement, nous avons examiné plus en détail l’analyse de la 
cartographie du destin cellulaire de Hoxa13 dans les pattes antérieures en développement. 
Nous avons pu déterminer que, dans le squelette du membre, tous les éléments 
squelettiques de l’autopode (main), à l’exception de quelques cellules dans les éléments 
carpiens les plus proximaux, proviennent des cellules exprimant Hoxa13. En contraste, 
nous avons découvert que, au sein du compartiment musculaire, les cellules exprimant 
Hoxa13 et leurs descendantes (Hoxa13lin+) s’étendent à des domaines plus proximaux du 
membre, où ils contribuent à générer la plupart des masses musculaires de l’avant-bras et, 
en partie, du triceps. De façon intéressante, nous avons découvert que les cellules exprimant 
Hoxa13 et leurs descendantes ne sont pas distribuées uniformément parmi les différents 
muscles. Au sein d’une même masse musculaire, les fibres avec une contribution 
Hoxa13lin+ différente peuvent être identifiées et les fibres avec une contribution semblable 
sont souvent regroupées ensemble. Ce résultat évoque la possibilité que Hoxa13 soit 
impliqué dans la mise en place de caractéristiques spécifiques des groupes musculaires, ou 
la mise en place de connections nerf-muscle.  
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Prises dans leur ensemble, les données ici présentées permettent de mieux comprendre le 
rôle de Hoxa13 au sein des compartiments embryonnaires et extra-embryonnaires. Par 
ailleurs, nos résultats seront d’une importance primordiale pour soutenir les futures études 
visant à expliquer les mécanismes transcriptionnels soutenant la régulation des gènes Hoxa 
dans les tissus extra-embryonnaires.  
 
Mots-clés : gènes Hox, allantoïde, placenta, muscles, régulation transcriptionnelle. 
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Abstract 
The Hox family of transcription factors is well known for its key contribution in the 
establishment of the body architecture in all the animal kingdom. During vertebrate 
evolution, Hox genes have been co-opted to pattern a variety of novel tissues/organs. Often, 
this diversification has been achieved by changes in Hox transcriptional control.  
In mammals, Hoxa13 function is not restricted to the embryo proper, but is also essential 
for the proper development of the fetal vasculature within the placental labyrinth, 
suggesting that its function in this structure accompanied the emergence of placental 
species.  
In chapter 2, we report on the recruitment of two other Hoxa genes, namely Hoxa10 and 
Hoxa11, in the extra embryonic compartment. We show that Hoxa10, Hoxa11 and Hoxa13 
expression is required in the allantois, the precursor of the umbilical cord and fetal 
vasculature within the placental labyrinth. Interestingly, we found that Hoxa10-13 gene 
expression in the allantois is not restricted to placental mammals, but is also present in a 
non-placental vertebrate, indicating that the recruitment of these genes in the allantois most 
likely predates the emergence of placental species. We generated genetic rearrangements 
and used transgenic assays to investigate the regulatory mechanisms underlying Hoxa gene 
expression in the allantois. We identified a 50 kb intergenic fragment able to drive reporter 
gene expression in the allantois. However, we found that the regulatory mechanism 
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controlling Hoxa gene expression in the extra-embryonic compartment is very complex and 
relies on more than one cis-regulatory element.  
In chapter 3, we used genetic fate mapping to assess the overall contribution of Hoxa13 
expressing cells to the different embryonic structures. In particular, we focused on Hoxa13 
fate-mapping analysis in the developing forelimbs. We could determine that, in the limb 
skeleton, all autopod (hand) skeletal elements, with the exception of a few cells in the most 
proximal carpal elements, originate from Hoxa13 expressing cells. In contrast, we found 
that, in the muscle compartment, Hoxa13 expressing cells and their descendants extend to 
more proximal limb domains, where they contribute to most of the muscle masses of the 
forearm and, in part, to the triceps. Interestingly we found that Hoxa13 expressing cells and 
their descendants are not identically distributed among different muscles.  Within the same 
muscular mass, fibres with different Hoxa13lin+ contribution can be identified, and fibers 
with similar contribution are often clustered together. This result raises the possibility that 
Hoxa13 might be involved in establishing specific features of muscle groups, or in 
establishing nerve-muscle connectivity.  
Altogether, the data presented herein provide a better understanding of the role of Hoxa13 
in both the embryonic and extra-embryonic compartment. Moreover, our results will be of 
key importance for further investigations aimed at unravelling transcriptional mechanisms 
underlying Hoxa gene regulation in extra embryonic tissues.  
 
Keywords: Hox genes, allantois, placenta, muscles, transcriptional regulation.  
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 Chapter 1: Introduction 
 
  
1.1 The Hox genes.  
1.1.1 Key features of Hox genes.  
Members of the Hox gene family play a pivotal role in axial patterning of animals 
with bilateral symmetry, among which they are surprisingly conserved (Carroll, 1995; 
Duboule, 1992; Krumlauf, 1994). Hox genes were first identified in the fruit fly Drosophila 
melanogaster, in which they confer segment identity along the primary anterior-posterior 
(AP) body axis (Lewis, 1978). When mutated in the fly, loss of Hox genes cause dramatic 
homeotic phenotypes, conditions in which one body segment is transformed into the 
identity of another one. It was subsequently discovered that Hox genes code for 
transcription factors sharing a sequence of 60 amino acids DNA-binding domain, referred 
to as the homeodomain (Scott and Weiner, 1984), related to the helix-turn-helix motif of 
prokaryotic DNA-binding proteins (Kissinger et al., 1990; Otting et al., 1990). Despite their 
key function during embryogenesis, relatively little is known about the molecular events 
that these transcription factors trigger. Hox proteins bind DNA with little specificity, 
recognizing a core sequence composed by only four nucleotides. Moreover, due to the high 
conservation of the homeodomain, most Hox proteins bind in vitro to simple sequences 
with the same affinity (Ekker et al., 1994; Hoey and Levine, 1988). This suggests that the 
specificity achieved by these transcription factors in vivo is most likely due to the additional 
presence of cofactors on target genes promoters. Different Hox co-factors have been 
identified, including members of the Pbx and Meis TALE homoedomain transcription 
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factors (reviewed for example in (Mann and Affolter, 1998; Moens and Selleri, 2006)). 
Multiprotein complexes composed by Hox and cofactors bind DNA sequences, acting both 
as activators or repressors of transcription.  
In most vertebrates 39 Hox genes have been identified. These genes are clustered on 
four genomic loci spanning over 100 to 150 kilobase pairs (kb), referred to as HoxA, B, C 
and D clusters. Each Hox cluster contains a series of nine to eleven contiguous genes 
transcribed from the same DNA strand, thus defining a 5’ to 3’ polarity to the cluster. 
Genes are referred to paralogous groups 1 to 13 based on their sequence similarity with 
genes located on the other clusters. Even if some paralogous group are missing in each 
cluster, the gene order is always maintained, such that group 1 genes are always located at 
the 3’ end of the complex, and group 13 at the 5’ (Krumlauf, 1992; Scott, 1992) (Fig. 1.1).  
3’ 5’
HoxA
HoxB
HoxC
HoxD
anterior posterior
Figure 1.1 Hox gene clusters in the mouse. 
In the mouse, as in most vertebrates, 39 Hox genes have been identified. These
genes are clustered on four genomic loci, referred to as HoxA, B, C and D clusters.
Each Hox cluster contains nine to eleven contigous genes transcribed from the
same DNA strand, conferring a 5’ to 3’ polarity of the cluster. Hox genes are 
expressed in overlapping domains during embryogenesis, such that their anterior 
limit of expression is collinear with the gene positions along the complex. 
Accordingly, genes located at the 3’ of each Hox clusters are expressed in more 
anterior structures of the developing embryo, while more 5’ Hox gene transcripts 
are restricted to more posterior domains of the body. 
(modified from Pearson et. al 2005)
4
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1.1.2 Evolution of Hox gene clusters.  
Importantly, the function of Hox genes in patterning the AP axis is conserved 
among all species, and changes in the body plan organization among different species are 
generally associated with changes in Hox gene number, pattern or boundary of expression 
(Burke et al., 1995; Cohn and Tickle, 1999). Hox genes have been identified in all 
bilaterian animals investigated so far (de Rosa et al., 1999), and, in most cases, they show a 
clustered organization, with the exception of the platyhelminth Schistosoma mansoni and 
the urochordate Oikopleura dioica, in which Hox genes are found scattered in the genome, 
with little if any linkage (Pierce et al., 2005; Seo et al., 2004).  Despite its evolutionary and 
developmental significance, the origin of the Hox gene clusters remains obscure. However, 
the highly conserved organization described in most bilaterian Hox clusters indicates that 
the common bilaterian ancestor had a set of clustered Hox genes. It has been proposed that 
during early evolution, an ancestral ProtoHox cluster has emerged by tandem gene 
duplication in cis of a single ancestral ProtoHox gene (Garcia-Fernandez, 2005). This early 
gene amplification would also explain the clustered organization of Hox genes that is found 
already in cnidarians (animals with a radial symmetry) (Chourrout et al., 2006; Ryan et al., 
2007). Subsequently, whole cluster duplication and split of the resulting sister clusters 
generated the Hox and ParaHox clusters (Brooke et al., 1998). From this putative ground 
state, a wide variety of Hox gene organizations have evolved. In all invertebrates 
investigated so far, including the insect Drosophila melanogaster, only one single Hox 
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cluster has been identified. The Drosophila Hox cluster (HOM-C) contains eight genes: 
Labial (lb), Proboscipedia (Pb), Deformed (Dfd), Sex comb reduced (Scr), Antennapedia 
(Antp), Ultrabihtorax (Ubx), Abdominal-A (Abd-A) and Abdominal-B (Abd-B). This single 
cluster was split into two sub-clusters, the Antennapedia (ANT-C) containing the first five 
genes, and the Bithorax (BX-C) containing the last three (Kaufman et al., 1980). The 
consensus view is that a single Hox cluster was at the origin of vertebrate evolution, a 
situation potentially reflected today by the single cluster of the cephalochordate Amphioxus 
(Garcia-Fernandez and Holland, 1994). The number of Hox genes within the cluster 
increased during evolution, as exemplified by the expansion of the Abd-B-related gene 
repertoire in Amphioxus, leading to a cluster of 14 Hox genes in this organism (Ferrier et 
al., 2000).  This single ancestral Hox cluster was subsequently amplified in the vertebrate 
lineage, possibly following successive whole genome duplications near the origin of 
vertebrates. For example, the lamprey, a jawless primitive vertebrate, has three (possibly 
four Hox clusters) (Force et al., 2002; Irvine et al., 2002). In higher vertebrates, like 
mammals, two rounds of whole genome duplications most likely originated a total of four 
paralogous clusters, referred to as HoxA to HoxD. Members of each cluster can be 
classified in paralogy groups, from 1 to 13. Paralogy groups 1 to 8 are homologous to the 
Drosophila genes Labial, Proboscipedia, Deformed, Sex comb reduced, Antennapedia, 
Ultrabitorax, and Abdominal-A, while the paralogy group 9 to 13 are related to the 
Abdominal-B gene (Krumlauf, 1994). In teleost fishes, an additional round of genome 
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duplication occurred, generating seven Hox clusters in zebrafish, one of the HoxD clusters 
being lost (Amores et al., 1998; Woltering and Durston, 2006). Interestingly however, the 
total number of genes in zebrafish is not much higher than in other species with only four 
clusters, most of the duplicated genes being lost.  
It was proposed that the expansion of Hox clusters resulted in looser evolutionary 
constraints on Hox genes, allowing them to acquire novel functions (Holland and Garcia-
Fernandez, 1996). Accordingly, the duplication of Hox clusters in higher vertebrates was 
accompanied by gene loss: as a result, none of the four Hox clusters displays all 13 
paralogy groups. Comparing vertebrate Hox gene clusters with their invertebrate 
counterparts reveals that the firsts show the higher degree of organization (reviewed in 
(Duboule, 2007)). In fact, in vertebrates, Hox clusters are considerably more compact than 
in other species, and no non-Hox genes are found interspersed in the complexes, as it is the 
case for Drosophila and the sea urchin. Furthermore, in most vertebrates, repetitive 
sequences are excluded from the Hox clusters, arguing for a strong selective pressure to 
exclude the invasion by mobile genetic elements at the base of vertebrate evolution 
(Amemiya et al., 2008; Fried et al., 2004). An exception to repetitive elements exclusion 
within Hox complexes in vertebrates has been recently reported in both squamates (like 
lizards and snakes) and caecilieans (snake-like amphibians) (Di-Poi et al., 2009; Mannaert 
et al., 2010). Interestingly these organisms display a divergent body plan organization from 
the other vertebrates. Changes in Hox genes expression, possibly deriving from this altered 
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Hox cluster organization, have been proposed as a possible explanation for this striking 
morphological diversity (Di-Poi et al., 2010b). Two scenarios can account for the increased 
organization of vertebrate Hox genes. Either the tightly structured organization found 
nowadays in vertebrates represents the evolutionary ground state that eventually 
deteriorated during the evolution of other lineages, or, alternatively, a disorganized Hox 
complex underwent a “consolidation” and compaction process in the case of vertebrates 
(Duboule, 2007). To support this latter hypothesis, an increased regulatory complexity at 
vertebrate loci has been proposed as a potential evolutionary constraint for Hox cluster 
compaction, including both newly acquired expression specificity, as well as ancient 
collinear transcription mechanisms.  
1.1.3 Collinearity.  
One of the most fascinating features of Hox genes is the phenomenon of 
collinearity, which stands for the correspondence between gene order within each Hox 
cluster and the distribution of gene transcripts along the main body axis (reviewed in 
(Kmita and Duboule, 2003)). This property was first described in Drosophila, where the 
distributions of Hox transcripts, as well as their domain of action along the AP axis of the 
embryo, are collinear to the Hox gene location along the chromosome (Lewis, 1978). 
Subsequently, the same kind of “spatial collinearity” was found to occur also in vertebrates, 
where genes of all four clusters show expression territories along the AP axis according to 
  
 
9 
the relative position they occupy within their respective complexes (Duboule and Dolle, 
1989; Gaunt, 1988; Graham et al., 1989). Hox genes in vertebrates are expressed in 
overlapping domains during embryogenesis, such that their anterior limit of expression is 
collinear with the gene positions along the complex. Accordingly, genes located at the 3’ of 
each Hox clusters are expressed in more anterior structures of the developing embryo, while 
more 5’ Hox gene transcripts are restricted to more posterior domains of the body (Duboule 
and Dolle, 1989; Graham et al., 1989).  This “spatial collinearity”, analogous to the one 
described in Drosophila, is observed in a variety of tissues along the main body axis, such 
as the neural tube and the paraxial mesoderm, but also in the gastrointestinal tract and 
urogenital system (Gaunt, 1988; Yokouchi et al., 1995) (Graham et al., 1989). Additionally, 
similar links between gene order and nested expression domains are found in secondary 
body axis, such as the external genitalia and limbs (Dolle and Duboule, 1989; Dolle et al., 
1991; Haack and Gruss, 1993; Nelson et al., 1996).  
“Spatial collinearity” has been reported in all bilaterian organisms investigated so 
far, independently from the strict clustered organization of the Hox complex (as reported in 
C. elegans (Wang et al., 1993)). Strikingly, even organisms with a completely fragmented 
Hox gene organization present such a “trans-collinearity”, and Hox genes are still expressed 
in the body axis accordingly to groups of paralogy (Duboule, 2007; Seo et al., 2004).  This 
apparent lack of interdependence between clustering and “spatial collinearity” challenges 
the claim that this phenomenon might represent a major constraint on maintaining Hox 
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genes clustered together. Furthermore, in the mouse, randomly integrated transgenes 
carrying single Hox genes with relatively reduced neighboring sequence could reproduce 
major aspects of the endogenous gene’s spatial transcript distribution (Puschel et al., 1991; 
Whiting et al., 1991).  
However, a Hox transgene randomly inserted into the genome shows some 
differences in the temporal dynamics of activation as compared to the endogenous gene, 
raising the possibility that the clustering of Hox genes is required for the fine-tuning during 
Hox gene activation process. In fact, unlike Drosophila genes, vertebrate Hox genes display 
an additional degree of complexity, resulting in the link between the onset of their 
expression during development and their position inside the complexes. This phenomenon 
is referred to as “temporal collinearity” and is observed in all vertebrates, in both the 
primary and secondary axes of the developing embryo ((Dolle and Duboule, 1989); 
reviewed in (Deschamps and van Nes, 2005)).  In the vertebrate primary body axis, Hox 
genes start to be expressed during early gastrulation, following a subsequent activation 
from the 3’ end to 5’ end of the clusters. This process is completed by late tail bud stage, 
around embryonic day 9 (e9) (Dolle et al., 1989; Izpisua-Belmonte et al., 1991). Genes 
activated early on are expressed in more anterior structures of the embryo, while genes 
activated later on are progressively restricted to more posterior embryonic compartments.  
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1.2 Hox gene function. 
1.2.1 Homeotic transformations. 
Genetic analysis in Drosophila has shown that mutations in Hox genes give rise to 
transformation of a specific part of the body of the fly into a completely different one: this 
phenomenon is called homeotic transformation. For example, in the Antennapedia 
mutation, the fly develops an extra pair of legs in place of the antenna, while the Bithorax 
mutation leads to the growth of an extra pair of wings (Lewis, 1978). It was shown that loss 
of function mutation in Hox genes usually lead to anteriorizing homeotic transformations, 
i.e., the transformation of a body segment into a more anterior one. Vice-versa, gain of 
function of a specific Hox gene anterior to the position in which it is normally expressed 
imposes a posterior identity to the segment where the Hox gene is ectopically expressed 
(Akam, 1987; Lewis, 1978; McGinnis and Krumlauf, 1992). Results obtained over the last 
three decades have demonstrated that the function of Drosophila Hox genes in specifying 
the identity of the different body segments along the AP axis is largely conserved in 
vertebrates. Each of the 39 Hox genes, as well as entire Hox clusters, has been genetically 
inactivated in the mouse. In parallel, classical transgenesis in the mouse was used to 
investigate the phenotypic outcomes of misexpressing a specific Hox gene in an embryonic 
domain in which it is not normally expressed.  
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Altogether, these studies have provided much support to the idea that vertebrate Hox 
genes, as well as their Drosophila counterparts, can specify morphological identity of 
metameric structures in the body plan. This view is also supported by evidence in other 
animal model organisms, like Xenopus and Zebrafish, in which mRNA injections or 
antisense approach experiments have been performed (Cho et al., 1991; McClintock et al., 
2002).  
 
1.2.2 Hox gene function in the primary vertebrate body axis. 
During vertebrate embryogenesis the extension of the body along the AP axis is 
coupled with the process of somitogenesis. The segmented structure of the vertebrate body 
plan is mostly apparent at the level of somatic mesoderm derivatives, such as the vertebrae, 
but also at the level of the central nervous system, where, for example, the hindbrain is 
subdivided into eight rhombomeres. Consistently, alteration of Hox expression mainly 
affects the morphology of these segmented structures (reviewed in (Burke, 2000; Lumsden 
and Krumlauf, 1996; Trainor and Krumlauf, 2001)).  
“Hox code” and posterior prevalence: 
In vertebrates, Hox expression patterns in the trunk, unlike in Drosophila, is 
characterized by large domains of expression, partially overlapping in the posterior region 
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of the main body axis. This led to the hypothesis that the identity of segments at different 
axial levels of the embryo relies on a different combination of Hox proteins, referred to as 
the “Hox code” (Kessel and Gruss, 1991). However, loss-of-function experiments in the 
mouse usually lead to morphological changes confined to the most rostral segments in 
which a given Hox gene is normally expressed. These observations indicate that a 
functional hierarchy exists among Hox genes, and that the most posterior Hox gene that is 
expressed in a determined segment imposes its function over more anterior Hox genes. This 
model is referred to as “posterior prevalence” (Duboule and Morata, 1994). In this view, 
nested and overlapping expression domains are only a way to confer discrete identities to 
the undifferentiated extending body axis. Notably, the phenomenon of “posterior 
prevalence” is not limited to the main body axis, but occurs also in secondary axis, like the 
limbs (see e.g. (Herault et al., 1997; Kmita et al., 2002a; Peichel et al., 1997; van der 
Hoeven et al., 1996)). “Posterior prevalence” is related to the phenomenon of “phenotypic 
suppression” described in Drosophila. Unlike in vertebrates, the distribution of Hox 
transcripts along the body axis in Drosophila is characterized by largely non-overlapping 
patterns. Posterior Hox proteins were shown to down-regulate the expression of more 
anterior Hox genes. Ectopic expression of Hox genes in Drosophila, however, demonstrated 
that this effect does not involve transcriptional repression, but rather acts at the post-
transcriptional level (Duboule and Morata, 1994).  
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Loss-of-function phenotypes: 
As mentioned earlier, loss-of-function mutations induce anteriorization mainly 
confined to the region corresponding to the anterior limit of expression of a given Hox 
gene. For example, the inactivation of Hoxa1, which is normally expressed up to 
rombobere 4 (r4) in the hindbrain, produces abnormalities only in r4 to r8 and their 
derivatives, leaving more anterior or posterior structures of the body unaffected (Carpenter 
et al., 1993; Chisaka et al., 1992; Lufkin et al., 1991).  The inactivation of Hoxa2 leads to 
anterior homeotic transformation of the cranial neural crest derivatives from the second 
branchial arch to a first branchial arch identity (Gendron-Maguire et al., 1993; Rijli et al., 
1993).  
In the axial skeleton, inactivation of Hox genes leads to anterior transformation of 
vertebrae. For example, Hoxa4 mutants show partial transformation of the third cervical 
vertebra (C3) towards a C2 identity (Kostic and Capecchi, 1994). Inactivation of Hoxb4 or 
Hoxd4 leads to partial transformation of C2 into C1 (Horan et al., 1995a; Ramirez-Solis et 
al., 1993). In more posterior domains of the trunk, homeosis of thoracic vertebrae is 
observed in many mutants. For example, Hoxc4 inactivation leads to anterior 
transformation of the third thoracic vertebra (T3) (Saegusa et al., 1996).  Hoxc8 mutants 
show anterior transformation of T8 to T7 and of the fist lumbar vertebrae (L1) to T13 (Le 
Mouellic et al., 1992). Finally, several examples of inactivations of Abd-B- related genes 
illustrate the requirement for these genes in conferring proper lumbo-sacral vertebral 
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identity. Following inactivation of Hoxa9, anterior homeosis of the first five lumbar 
vertebrae is observed (Fromental-Ramain et al., 1996a). Inactivation of the paralogous 
Hoxd9 leads to anterior transformations from L3 to the first caudal vertebra, which assumes 
a sacral identity (Fromental-Ramain et al., 1996a). Similarly, upon Hoxd11 inactivation, the 
sacral region displays anterior transformation, resulting in a posterior shift of the sacrum 
(Davis and Capecchi, 1994; Favier et al., 1995).  
Gain-of-function phenotypes: 
In many cases, ectopic Hox expression leads to posterior transformations, mainly 
restricted to regions of the body that are rostral to the normal limit of expression of the 
gene. For example, ectopic widespread expression of Hoxa1 leads to rhombomere 
transformation, resulting in change of r2 and r3 towards r4 identity (Zhang et al., 1994). 
Ectopic expression of Hoxa7 under the control of the ubiquitous β-actin promoter leads to 
the appearance of an additional first cervical vertebra and other severe cranio-facial defects 
(Kessel et al., 1990). The expression of Hoxd4 under the control of the Hoxa1 promoter 
leads to transformation of the occipital bones into structures resembling cervical vertebrae, 
since neural arches are induced (Lufkin et al., 1992). Hoxb8 expression under the retinoic 
acid receptor (RAR) β2 promoter leads to cervical vertebrae adopting a more posterior 
identity (Charite et al., 1995).  
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Unexpected phenotypes: 
In some cases, Hox gene inactivation results in posterior, rather than anterior 
transformations, or in a complex combination of both. These results may, however, reflect 
technical limitations of gene-targeting technology as it was originally developed. For 
instance, mice lacking Hoxb2 present partial transformation of C2 in C1 and splitting of the 
sternum into two longitudinal structures (Barrow and Capecchi, 1996). This sternal defect 
is reminiscent of Hoxb4 inactivation, and consistently, Hoxb4 expression is decreased or 
suppressed in these mutants. In parallel, Hoxb2 mutant mice display facial paralysis, as do 
mice with Hoxb1 inactivation (Goddard et al., 1996). Accordingly, Hoxb1 expression in 
neural crest cells is abrogated in these mutants (Barrow and Capecchi, 1996). Hoxa11 
inactivation leads to posterior homeotic transformation probably linked to Hoxa10 
misexpression (Branford et al., 2000; Small and Potter, 1993). 
Targeting constructs employed to generate gene inactivation typically include a 
selection cassette, to allow selection of integration events in ES cell clones. The presence of 
strong promoters in the selection cassettes, such as the phosphoglycerate kinase promoter 
(PGK), can perturb the regulation of neighboring genes, competing for enhancer activity, 
or, alternatively, the targeting of the cassette can disrupt regulatory elements, ultimately 
leading to loss or gain-of-expression of one or several genes (Beckers and Duboule, 1998; 
Rijli et al., 1994; Zakany et al., 1997b).  More recently, the Cre-loxP recombinase approach 
has been used to ultimately remove the selection cassette. However, most Hox gene 
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inactivations were produced before the advent of this technique, and still include the 
selection cassette. Thus, the resulting phenotypes should be interpreted with caution.  
Conversely, Hox gene gain of function can also induce unexpected anterior 
vertebral transformations. For example, transgenic mice carrying over 40 copies of a human 
Hoxc6 transgene present anterior transformation of thoracic and lumbar vertebrae. 
However, this doesn’t happen when a lower copy number of the transgene is integrated, 
suggesting that a quantitative effect is responsible for the former phenotype (Jegalian and 
De Robertis, 1992). More recently, to circumvent this problem, single-copy integration of a 
transgene can be achieved using retroviruses and transposons (Ding et al., 2005; Lois et al., 
2002; Mates et al., 2009). 
Functional redundancy: 
In some cases, the inactivation of a single Hox gene does not result in any obvious 
phenotype. This is the case for instance with Hoxa7 and Hoxd8 mutation (Chen et al., 1998; 
van den Akker et al., 2001). In general, compared to the drastic effect of homeotic 
transformation in Drosophila, loss-of-function mutations in mice result in relatively mild 
effects.  
For example, inactivation of the Hox4 paralogs (Hoxa4, Hoxb4 and Hoxd4) results 
in dose dependent increase in the severity of the resulting phenotype, leading to an 
increment in the number of cervical vertebrae adopting a C1 identity, compared to what is 
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observed in single mutants (Horan et al., 1995a; Horan et al., 1995b). Inactivation of Hox9 
paralogs (Hoxa9, Hoxb9, Hoxc9 and Hoxd9) leads to transformation of posterior thoracic 
and anterior lumbar vertebrae into a more anterior thoracic morphology (McIntyre et al., 
2007). Surprisingly, the presence of a single wild-type allele out of eight was sufficient to 
drastically reduce the severity of all these observed phenotypes. The inactivation of Hox10 
paralogs (Hoxa10, Hoxc10 and Hoxd10) results in mice with transformation of all lumbar 
vertebrae into rib-bearing structures, similar to thoracic vertebrae. Moreover, inactivation 
of Hox11 paralogs (Hoxa11, Hoxc11 and Hoxd11) causes transformation of sacral 
vertebrae to a lumbar phenotype (Wellik and Capecchi, 2003).  Also in these cases, the 
presence of a single wild-type allele out of eight could drastically reduce the severity of the 
phenotypes observed in Hox triple mutants (Fig. 1.2).  
Thus, the duplication of the ancestral Hox cluster in the vertebrate lineage, and the 
resulting generation of different members for the same paralogy group, is likely to account 
for this effect. This suggests that Hox genes of the same paralogy group, if not others, can 
have partially redundant functions.  
In other cases, genetic interactions among paralogs are more complex. For example, 
Hoxa3 and Hoxd3 single mutants do not display overlapping phenotypes, even if they are 
expressed in the same structures. However, double gene inactivation causes exacerbation of 
both individual phenotypes revealing an unexpected synergism (Chisaka and Capecchi, 
1991; Condie and Capecchi, 1993). Another interesting result is obtained by combined 
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gene inactivation of Hoxb8, Hoxc8 and Hoxd8. Single mutants display some distinct 
phenotypes (Le Mouellic et al., 1992; Tiret et al., 1993; van den Akker et al., 1999). 
Nevertheless, compound inactivation reveal synergistic interaction in the patterning along 
the AP axis, yet some phenotypes observed in Hoxc8/Hoxd8 double mutants are rescued by 
Hoxb8 inactivation, suggesting that qualitative differences among Hox8 paralogous proteins 
may exist (van den Akker et al., 2001).  
Even though Hox paralogous genes show closer sequence similarity than 
neighboring genes of the same cluster, there are several examples of functional redundancy 
among non-paralogous genes located in trans or even in cis. If we look at Hoxa10 and 
Hoxd11 compound mutants, animals display up to eight lumbar vertebrae with concomitant 
shift of the sacrum, a phenotype reminiscent of Hoxa11/Hoxd11 compound mutants, but 
distinct from single mutants involving Hoxa10, Hoxa11 or Hoxd11 inactivation (Favier et 
al., 1996). In some other cases, functional redundancy was even reported between 
neighboring genes in cis. Hoxb5/Hoxb6 trans-heterozygous mutants show the same 
phenotype as both homozygous, carrying C6 to C5 and T1 in C7 anterior transformations 
(Rancourt et al., 1995).  
Many other examples of functional redundancy have been reported in other tissues, 
such as the limbs (see for example (Fromental-Ramain et al., 1996a; Fromental-Ramain et 
al., 1996b; Wellik and Capecchi, 2003)) or the kidney (Davis et al., 1995).   
Figure 1.2 Homeotic transformations and functional redundancy among 
paralogous Hox genes.   
Representation of a wild-type skeleton (B).The inactivation of Hox10 paralogs 
(Hoxa10, Hoxc10 and Hoxd10) results in mice with transformation of all lumbar 
vertebrae (yellow) into rib-bearing structures, similar to thoracic vertebrae (A). 
Inactivation of Hox11 paralogs (Hoxa11, Hoxc11 and Hoxd11) causes transformation 
of sacral vertebrae (red) to a lumbar phenotype (C). Surprisingly, the presence of a 
single wild-type allele out of eight is sufficient to reduce drastically the
observed phenotype (D, E). 
(modified from Wellik and Capecchi, 2003) 
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1.2.3 Hox genes and evolutionary novelties.  
In the course of vertebrate evolution, besides their ancestral function in patterning 
the main body axis, Hox genes have been recurrently co-opted to pattern novel structures of 
the body. Due to two rounds of whole-genome duplications, higher vertebrates present four 
Hox clusters and thus up to four paralogous genes for each paralogy group. The presence of 
up to four paralogous genes allowed the allocation of different functions to different genes, 
often through the acquisition of new expression specificities. In this section, I will review 
some examples relevant for this thesis and subsequently discuss the specific functions of 
Hoxa13 in embryonic and extra-embryonic structures.  
Hox gene functions in the limbs: 
The vertebrate limb is one of the most important morphological adaptations that 
enabled the transition from aquatic to the terrestrial environment in the course of vertebrate 
evolution. Work from different laboratories has demonstrated that Hox genes have been 
recruited to pattern this secondary body axis. Gain and loss-of-function experiments have 
demonstrated that 5’ members of the HoxA and HoxD clusters are essential for the proper 
patterning and growth of limb skeleton. Genes of these two clusters are expressed in 
complex and dynamic patterns during forelimb and hindlimb development, characterized 
by two different waves of expression (reviewed in (Zakany and Duboule, 2007)). In the 
early limb bud, 5’ Hoxa and Hoxd genes are sequentially activated in time and space, 
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reminiscent of the spatial and temporal collinearity occurring in the trunk and their 
expression patterns are progressively restricted towards the posterior margin of the bud 
(Dolle et al., 1989; Haack and Gruss, 1993). Later in development, during the second wave 
of expression, genes of the HoxA and HoxD clusters show a quite distinct and more 
complex expression profile. In fact, while Hoxd gene expression still show an anterior-
posterior polarity, Hoxa genes rapidly loose this posterior restriction, but are progressively 
confined to the distal limb domain (proximo-distal polarity). This observation suggests that 
the regulatory mechanisms underlying Hoxa and Hoxd gene expression in this second phase 
of expression may have evolved separately, after cluster duplication occurred (Zakany and 
Duboule, 2007).   
It was proposed that the appearance of the second wave of Hox genes expression in 
the developing limb accompanied the evolution of the most distal limb structures, the 
digits, from an ancestral fin-like appendage (described as the “fin to limb” transition) 
(Sordino et al., 1995). However, this view was recently challenged by the discovery that 
two waves of Hox gene expression are also present in different fishes (Ahn and Ho, 2008; 
Davis et al., 2007; Freitas et al., 2007; Johanson et al., 2007). Only the analysis of 
regulatory elements in fishes, and the comparison with the ones already identified in the 
mouse, will help to understand whether tetrapod digits are an adaptation of pre-existing 
structures or are a functional novelty that has evolved together with specific new regulatory 
elements (Woltering and Duboule, 2010).  
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Patterning defects along the proximo-distal (PD) axis of the limb, caused by Hox 
gene inactivation, are collinear with the gene position in the complex. Mutation in Hoxa9 
and Hoxd9 paralogs leads to mild growth defects in the most proximal domain of the limb, 
the stylopod, group 11 gene inactivation affects the intermediate region of the limb, the 
zeugopod, Hoxa13 and Hoxd13 mutants display defects in the digits and carpal/tarsal bones 
(Davis and Capecchi, 1994; Fromental-Ramain et al., 1996b; Small and Potter, 1993). 
Compound Hoxa and Hoxd paralogous gene inactivation usually results in much more 
severe phenotypes than single gene inactivation (Davis et al., 1995; Fromental-Ramain et 
al., 1996b). Finally, the complete deletions of the HoxA and HoxD clusters in the limbs 
result in early developmental arrest, leading to a truncated limb at the proximal level of the 
humerus (Kmita et al., 2005).  
Hox genes functions in external genitalia and reproductive tract: 
Interestingly, group 9 to group 13 genes of the HoxA and HoxD clusters are also 
expressed in the genital bud, the structure that will give rise to external genitalia. Deletion 
of group 13 paralogous genes results in a similar dose-dependent reduction of both penian 
bone and digits (Kondo et al., 1997; Zakany et al., 1997a). Both external genitals and digits 
develop in a similar way and share a number of common signalling pathways (Yamada et 
al., 2006). Most recently, similar regulatory mechanisms have been identified for both 
structures. Enhancer sequences for both limb and genitals reside on the centromeric side of 
the HoxD cluster (Spitz et al., 2001; Spitz et al., 2005). Moreover, the Ulnaless inversion, 
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in which Hoxd genes are moved away from regulatory sequences located on the 
centromeric side of the cluster, results in down-regulation of Hoxd genes in both digits and 
genitals (Spitz et al., 2003). Transgenic assays also demonstrated that enhancer elements 
able to drive reporter gene expressing in the limbs are also active in the genitals (Gonzalez 
et al., 2007). Finally, Hoxd genes are expressed in a quantitative collinear manner in both 
structures (Montavon et al., 2008). Altogether, this suggests that the acquisition of new Hox 
expression specificities has been instrumental for the emergence of both digits and external 
genitalia during evolution, these structures being a combined adaptation to terrestrial life, 
allowing for both effective locomotion and internal fertilization.  
 Placental mammals present essential innovations compared to other animals, such 
as the differentiation of the oviducts into uterus and upper vagina, the presence of a highly 
specialized epithelium, referred to as the endometrium, and the placenta, a specialized 
organ that mediates the feto-maternal exchanges (Wagner and Lynch, 2005). 5’ Hoxa genes 
are expressed in a collinear manner in the female reproductive tract, such that Hoxa9 
transcript is detected in the oviduct, Hoxa10 in the developing uterus, Hoxa11 in the uterus 
and cervix and Hoxa13 in the upper vagina (Taylor et al., 1997; Warot et al., 1997). 
Hoxa10 is expressed in the uterine epithelium and is up-regulated during implantation, 
when the uterine stroma is transformed into decidua. Hoxa10 inactivation leads to anterior 
homeotic transformation of the uterus in oviduct and homozygous mutant females are 
partially infertile, as a result of implantation defects (Benson et al., 1996; Satokata et al., 
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1995). Similarly, females lacking Hoxa11 present with a small uterus and implantation 
defects (Gendron et al., 1997; Hsieh-Li et al., 1995). The combined inactivation of Hoxa11 
and Hoxd11 results in anterior homeotic transformation of the male reproductive tract, 
while Hoxd11 loss-of-function confers male sterility (Davis et al., 1995).  
 
1.2.4 Hoxa13 functions in the embryo proper.  
Preliminary insights into Hoxa13 gene function came from the discovery that the 
mouse spontaneous mutant “Hypodactyly” (Hd) carries a deletion of 50 base pairs (bp) in 
the Hoxa13 coding sequence (Mortlock et al., 1996). The Hd mutation was first described 
in 1970 (Hummel, 1970) as a semidominant mutation leading to digit defects and 
shortening of digit I in heterozygous animals, while the majority of Hd/Hd embryos die in 
utero. Rare homozygous survivors are infertile and display severe autopod defects, 
characterized by the presence of only one digit and defects in carpal and tarsal elements 
(Hummel, 1970; Mortlock et al., 1996). Subsequently, two loss-of-function alleles have 
been generated in mice. The first engineered inactivation of Hoxa13 (referred to as 
Hoxa13-/-) disrupts the homeobox in the second exon (Fromental-Ramain et al., 1996b) 
and the second Hoxa13 loss-of-function allele was generated by targeting of a green 
fluorescent protein (GFP) into exon 2 (hereafter referred to as Hoxa13GFP) (Stadler et al., 
2001). Interestingly, the limb phenotype of these Hoxa13 mutants is much less severe than 
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the Hd/Hd one. In fact, it was found that the Hd mutation leads to the production of a 
dominant negative Hoxa13 protein, in which the first wild-type 25 amino acids are 
followed by 275 new residues, resulting from the frame-shift caused by the 50 bp deletion 
in the gene sequence (Post et al., 2000). In the limb bud of these mutants the expression of 
other Hox genes is impaired and massive cell-death is detected (Post and Innis, 1999).  
Many spontaneous mutations in different regions of the Hoxa13 gene have been 
described in humans, causing the Hand-Foot-Genital syndrome (HFGS) (Frisen et al., 
2003; Goodman et al., 2000; Jorgensen et al., 2010; Mortlock and Innis, 1997; Utsch et al., 
2007). HFGS is a rare, dominantly inherited condition in which affected individuals present 
a phenotype very similar to the one of heterozygous Hd mutants, including digit 1 
hypoplasia (short digit 1), brachydactyly (shortening) of the other digits and brachydactyly 
and clinodactyly (curvature) of digit 5. HFGS is also accompanied by lower genito-urinary 
tract malformations, such as hypospadias in males and Mullerian duct fusion defects in 
females, leading in the most severe cases to the presence of a “duplicated uterus” together 
with ectopic ureteric orifices (Poznanski et al., 1975; Stern et al., 1970) (Donnenfeld et al., 
1992; Halal, 1988). 
Hoxa13 functions in the limb.  
In the mouse, Hoxa13 starts to be expressed in the posterior and distal part of the 
limb bud around e10. At e12.5 its expression is detected in the entire presumptive autopod, 
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both in digit condensations and interdigital tissue and later, at e13.5-e14.5, Hoxa13 
transcript is restricted to peridigital tissue and interarticular condensations (Haack and 
Gruss, 1993; Stadler et al., 2001).  
Hoxa13-/- adults are not viable due to mid-gestation embryonic lethality. Hoxa13 
homozygous mutant embryos can be analyzed up to e15 and display limb abnormalities in 
the autopod of both forelimb and hindlimbs, characterized by lack of digit 1 chondrogenic 
condensation, variable syndactyly and barachydactyly of other digits, loss of the second 
phalangeal cartilage, and delayed or absent pre-cartilaginous condensation for carpal and 
tarsal elements. Rare homozygous mutants have been recently recovered after birth, 
allowing for the analysis of skeletal defects in adult mutants that confirmed previous 
conclusions (Perez et al., 2010). Heterozygous animals are fully viable and fertile and 
display only mild limb abnormalities, such as fusion of digits 2 and 3 at the level of the soft 
tissues and alteration of the claw of digit 1 (Fromental-Ramain et al., 1996b). 
Hoxa13/Hoxd13 compound mutants display a much more severe phenotype compared to 
the one observed in single loss-of-function inactivation and the severity increases 
progressively with the number of alleles inactivated (Dolle et al., 1993; Fromental-Ramain 
et al., 1996b). In fact, the most compromised autopod is observed in Hoxa13-/-; Hoxd13-/- 
embryos, which display almost complete digit loss and absence of carpal/tarsal 
condensations, demonstrating the fundamental importance of these paralogous genes in 
digit formation. Hoxa13 mutants show a more severe phenotype in limb domains where 
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Hoxa13 function cannot be completely compensated by its paralog Hoxd13, including the 
forming digit 1 and carpal/tarsal elements of the limb (Haack and Gruss, 1993) 
Subsequent studies have aimed to understand the molecular pathways regulated by 
Hoxa13. Studies using avian embryos suggested that Hoxa13 expression is important to 
confer cell-cell adhesiveness properties and that Hoxa13 expressing cells are able to 
selectively associate and form aggregates in vitro (Yokouchi et al., 1995). Further analysis 
demonstrated that Hoxa13 directly activates the expression of the tyrosine kinase receptor 
ephrin A7 (EphA7) in limb mesenchymal condensations, and that this activation is required 
for proper mesenchymal condensation in the limb autopod (Salsi and Zappavigna, 2006; 
Stadler et al., 2001). Moreover, Hoxa13 activates the expression of bone morphogenetic 
protein 2 and 7 (Bmp2 and Bmp7) in the autopod by binding to upstream sequences of these 
genes. In the developing limb, Bmp2 and Bmp7 are key regulators of chondrogenesis as 
well as interdigital programmed cell death (IPCD) required for proper digit separation 
(Macias et al., 1997; Merino et al., 1998; Yokouchi et al., 1996; Zou et al., 1997; Zou and 
Niswander, 1996; Zuzarte-Luis and Hurle, 2002). Decreased expression of Bmp2 and Bmp7 
thus underlies loss of IPCD in Hoxa13 homozygous mutants, leading to fused digits (Knosp 
et al., 2004).  
In addition to its function in skeletal pattering, Hoxa13 is also activated in myogenic 
progenitors of the limb, derived from the hypaxial dermomyotome of the somites. After 
these cells have entered the limb bud territory, some of them start expressing Hoxa13, and 
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Hoxa13 expression is maintained in limb the musculature at least until e13.5 (Yamamoto et 
al., 1998; Yamamoto and Kuroiwa, 2003). However, the functional relevance of Hoxa13 
expression in limb muscles remains unclear, and the phenotype of Hoxa13-/- mouse 
embryos has not been characterized for the presence of patterning or functional defects in 
the muscular tissues. Studies in chick showed that Hoxa13 expression in myogenic 
progenitors of the limb is not under the control of signals derived from the apical 
ectodermal ridge (AER), unlike Hoxa13 expression in mesenchymal cells, but is controlled 
by signals from the zone of polarizing activity (ZPA), via Bmp2 regulation (Hashimoto et 
al., 1999). One study has linked Hoxa13 function to the regulation of the transcription 
factor MyoD, which is involved in the process of muscular differentiation (reviewed in 
(Tajbakhsh and Buckingham, 2000)). Electroporation experiments in the chick and in vitro 
studies using myoblast cells showed that forced expression of Hoxa13 inhibits expression 
of MyoD and the expression of MyoD is consistently enhanced in Hoxa13-/- mutants 
(Yamamoto and Kuroiwa, 2003). However, the functional relevance of this regulation is 
not clear and further studies in this direction have not yet been performed, leaving the 
potential function of Hoxa13 expression in the limb musculature still largely unexplored.  
Hoxa13 function in the urogenital system and gastrointestinal tract. 
Hoxa13 and Hoxd13 are co-expressed in the mesenchyme of the genital bud and 
urogenital sinus and, at lower levels, in the urogenital sinus epithelium (Oefelein et al., 
1996; Podlasek et al., 1997; Warot et al., 1997). In particular, Hoxa13 is expressed in the 
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caudal portion of the Mullerian ducts, caudal portion of the ureters, in the developing 
bladder, in male prostate and seminal vesicles, in female cervix and vagina and in the 
epithelium of hindgut and rectum (Warot et al., 1997).  
Inactivation experiments have revealed an essential function for Hoxa13 and 
Hoxd13 in the development of urogenital system and gastrointestinal tract. Hoxa13-/- 
mutants display agenesis of the caudal part of the Mullerian ducts, abnormal location of 
ureter extremities, absence of developing bladder and, in general, hypoplasia of the entire 
urogenital sinus. In the genital bud, programmed cell death and cell proliferation are 
necessary for tissue remodelling and for proper growth and closure of the penile urethra. 
Hoxa13 function in this structure is essential for normal Bmp and Fgf signalling. 
Downregulation of Bmp7 and Fgf8 levels in Hoxa13-/- mutants reduces apoptosis and cell 
proliferation in the genital bud, causing hypospadia, a defect in urethral closure (Morgan et 
al., 2003). Hoxa13 inactivation also affects the vasculature within the distal part of the 
genital bud, which is characterized by abnormally dilated capillaries (Morgan et al., 2003). 
In the vascular endothelium of the genital bud, Hoxa13 directly binds discrete regions of 
the EphA6 and EphA7 promoters. Hoxa13 inactivation leads to EphA6 and EphA7 down-
regulation, making a possible link between reduced expression of these cell adhesion 
molecules and the abnormally dilated vessels within the genital bud (Shaut et al., 2007).  
In contrast, in the development of the gastrointestinal tract, simple inactivation of 
Hoxa13 does not cause overt abnormalities (Warot et al., 1997). As for the limbs, 
  
 
31 
Hoxa13/Hoxd13 compound mutants display a more severe phenotype, demonstrated by the 
complete absence of genital bud and fusion of hindgut and urogenital sinus into a cloaca-
like structure (Warot et al., 1997). Moreover, Hoxa13+/-; Hoxd13-/- mutants display 
gastrointestinal abnormalities more severe than in simple Hoxd13 loss-of-function, such as 
dilatation of the rectum with absence of rectal glands, together with defects of both the 
epithelial and the smooth muscle layers, the latter being detached from the mucosa and 
occasionally interrupted (Kondo et al., 1996; Warot et al., 1997). Altogether Hoxa13 and 
Hoxd13 expression in the posterior extremities of digestive, reproductive and excretory 
tracts suggests their potential role in the disappearance of the cloaca in some vertebrate 
species, such as placental mammals and teleost fishes, and in the evolution of a more 
complex anatomical configuration, in which digestive, reproductive and excretory functions 
are more clearly separated. 
Hoxa13 functions in the extra-embryonic compartment.  
In contrast to all other Hox genes, only Hoxa13 inactivation precludes the embryo 
from the completion of its in utero development (Fromental-Ramain et al., 1996b; Stadler 
et al., 2001). Hoxa13 homozygous mutants display midgestation lethality and cannot be 
recovered after e15 (Fromental-Ramain et al., 1996b). However, mutant embryos present 
grossly normal morphology, and the embryonic lethality was initially ascribed to partial 
stenosis of the umbilical arteries, even if this phenotype is not fully penetrant (Warot et al., 
1997). Subsequently, Shaut and collaborators uncovered a role for Hoxa13 in the 
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development of the vasculature within the placental labyrinth, which is characterized by 
reduced branching and reduced size of the overall structure in mutant homozygous tissues. 
The defective vasculature within the placental labyrinth likely accounts for the mid-
gestation lethality of Hoxa13-/- embryos. Lack of Hoxa13 function in the mutant 
labyrinthine vasculature results in down-regulation of pro-vascular factors in endothelial 
cells, such as Tie2, Foxf1 and Enpp2, suggesting that downregulation of these genes could 
partially account for the Hoxa13-/- placental phenotype (Shaut et al., 2008).  
 
1.3 The murine chorioallantoic placenta 
1.3.1 The placenta: overview. 
In eutherian mammals, the embryo starts and completes its development in the 
mother’s uterus, depending upon the mother for its survival during the entire pregnancy. 
During embryogenesis, the chorioallantoic placenta is the first organ to form and is 
essential to sustain embryonic survival and growth during gestation. The placenta forms the 
interface between the maternal and fetal environment, facilitating nutrient and gas 
exchanges, as well as removal of fetal waste products. The placenta is also an important 
source of pregnancy-associated hormones that alter maternal physiology during pregnancy 
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and acts as an immune barrier for the foetus, maintaining the separation of maternal and 
fetal circulation.  
As in humans, the murine mature placenta is formed of two major components: the 
decidua and the labyrinth (Fig. 1.3). The outer maternal layer includes decidual cells from 
the uterus and the maternal vasculature. The placental labyrinth is formed by highly 
branched endothelium and by trophoblast cells, which play structural and functional roles 
in bringing the maternal and fetal vasculature into close association. The umbilical cord and 
its vasculature connect the placenta to the developing embryo.  
All aspects of chorioallantoic development, including the formation of the allantois, 
i.e. the precursor of the umbilical cord, its growth, and the formation of the highly 
vascularized labyrinth layer are susceptible to genetic perturbations (Inman and Downs, 
2007; Rossant and Cross, 2001; Watson and Cross, 2005). In the last decade, the study of 
different mouse mutants presenting aberrant development of the different chorioallantoic 
placenta components shed some light on the molecular basis of placental development. 
However, even if extra-embryonic tissues are clearly essential to sustain growth and 
development of the embryo, much work remains to be done in order to fully characterize 
the molecular mechanisms governing their development.  
Figure 1.3 The murine placenta.  
The major regions and cell types of the mouse placenta at e15.5. (A) Schematic 
representation of a sagittal section through the center of the placenta. On the top,
the maternal part (decidua). Just below the spongiotrophoblast layer of the placenta
(grey). Highly branched fetal vasculature within the labyrinth is represented in 
blue and is connected with the umbilical cord (bottom). 
(b) Magnification of the boxed area in A, showing in more detail the labyrinthine 
feto-maternal interface (the zygote-derived tissue between fetal and maternal blood).  
In orange, the trilaminar layer of trophoblast cells which separates and mediates the 
exchanges between the maternal blood and the fetal vasculature. 
(adapted from Georgiades et al. 2001).
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1.3.2 Early development and the origin of embryonic and extra-
embryonic lineages in the mouse. 
Mouse gestation lasts around 20 days, and can be divided into three phases: pre-
implantation, implantation and post-implantation. During this time, the fertilized egg 
develops and gives rise to both embryonic and extra-embryonic structures (Fig. 1.4). The 
development of embryonic and extra-embryonic components is tightly linked and 
synchronized during the entire pregnancy.  
After fertilization, during the pre-implantation phase, the mouse zygote undergoes 
three rounds of cleavage, reaching 32-cell stage (e3.5). At this time, two cell populations 
are distinguishable and committed to different fates: the outer cell layer, or trophectoderm 
and a small cluster of inner cells, referred to as the inner cell mass. The spatial distribution 
of these two cell populations generates an inner fluid-filled cavity, the blastocoel. At this 
stage, the mouse embryo is called a blastocyst (Fig. 1.4). After an additional 24 hours of 
maturation, the blastocyst is ready to implant into the maternal uterine wall (e4.5). During 
the implantation process, the trophectoderm excavates a space in the uterine wall and 
becomes embedded into it, via a process that involves maternal participation through 
hormonal receptivity, and thus synchrony between the mother and the fetus. During the 
post-implantation phase, the trophectoderm begins to differentiate into extra-embryonic 
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ectoderm, and the inner cell mass gives rise to the epiblast and primitive endoderm 
lineages. The extra-embryonic ectoderm will subsequently originate the ectoplacental cone 
and the chorion. The ectoplacental cone will give rise to the outer population of trophoblast 
giant cells and the hormone secreting spongiotrophoblasts. The chorion will differentiate 
into the various labyrinth trophoblast cell subtypes. The primitive endoderm with its 
descendant, the extra-embryonic parietal and visceral endoderm, will form components of 
the parietal and visceral yolk sacs, structures that will function as temporary placenta, until 
the definitive chorioallantoic placenta is formed. The epiblast gives rise to the three 
primitive embryonic cell layers (embryonic ectoderm, endoderm and mesoderm), to the 
extra-embryonic mesoderm that forms the allantois that will subsequently give rise to the 
umbilical cord and to the amniotic ectoderm that forms to the amnion (reviewed e.g. in 
(Cockburn and Rossant, 2010; Simmons and Cross, 2005)). Recent data suggest that the 
three primitive embryonic cell layers do not entirely segregate at gastrulation and that 
common progenitors of both ectoderm and mesoderm can be identified at much later stages 
in the mouse (Tzouanacou et al, 2009).  
The intimate association of labyrinth trophoblast cells and allantois/umbilical cord-
derived vasculature eventually form the labyrinth layer of the placenta, which is the site of 
feto-maternal exchanges. The development of this essential structure is presented in the 
next section (see also Fig. 1.5).  
Figure 1.4 Stages of mouse preimplantation development.  
In the mouse, the fertilized egg undergoes three rounds of cleavage, producing
an eight-cell embryo that then undergoes compaction. From the eight-cell stage 
onward, cell divisions produce two populations of cells, those that occupy the inside 
of the embryo and those that are located on the outside. The blastocoel cavity begins 
to form inside the embryo beginning at the 32-cell stage and continues to expand as 
the embryo grows and matures into the late blastocyst stage.
(adapted from  Cockburn and Rossant, 2010)
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1.3.3 Labyrinth development.  
Gastrulation and emergence of the allantois.  
Between e4.5 and e6 the epiblast elongates and forms an internal cavity, assuming a 
U-shaped structure. Around e6.75 the process of gastrulation begins, with the formation of 
the primitive streak in the posterior region of the embryo. 24 hours after its formation, the 
primitive streak elongates towards its anterior limit, where a specialized structure referred 
to as the node will form.  The node sends forward a population of cells in the anterior 
midline, called the notochord. These cells give rise to the definitive endoderm and to 
mesoderm of the axial midline. At the same time, cells emerge in lateral directions from the 
primitive streak, generating the nascent embryonic mesoderm. Cells emerging at specific 
times and AP locations along the primitive streak will give rise to different mesoderm 
derivatives ((Kinder et al., 1999; Lawson et al., 1991; Tam and Beddington, 1987)). Cells 
from the epiblast ingress into the posterior primitive streak and emerge as extra-embryonic 
mesoderm in the extra-embryonic space ((Beddington, 1981; Lawson et al., 1991; Tam and 
Beddington, 1987)). The cell population that first completes this process gives rise to the 
mesodermal lining of the exocoelomic cavity (e7.25). Subsequently, another cell population 
ingresses through the posterior primitive streak to emerge as the allantoic bud, which 
remains in close continuity with the posterior primitive streak (Lawson et al., 1991). 
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The development of the allantois proceeds in parallel with specific stages of 
embryonic development (Downs and Davies, 1993). At the neural plate stage (e7.25-e7.5), 
the allantois emerges from the primitive streak as a bud containing an outer and an inner 
layer. The outer layer of squamous epithelial cells, the mesothelium, is characterized by the 
presence of both adherens junctions and desmosomes. The inner cells are known as the 
allantoic core (Downs and Gardner, 1995; Downs et al., 2004). The vascularization of the 
allantois occurs de novo, like the vascularization of the yolk sac and embryo. At late 
allantoic bud stage, in the distal tip of the allantois, the first angioblast cells begin to 
differentiate from the allantoic mesenchyme. These cells are endothelial progenitors that 
will form the primary vascular plexus within the allantois (Downs et al., 1998; Drake and 
Fleming, 2000).  
The molecular mechanisms leading to allantoic bud emergence are still poorly 
understood. However, loss-of-function inactivation for different genes leads to absence of 
allantoic bud emergence. Members of the Bmp family seem to have an essential role in this 
process. Bmp-4 mutants gastrulate properly, but fail to develop the allantoic bud (Lawson et 
al., 1999; Winnier et al., 1995). Embryos carrying a mutation of another member of the 
Bmp family, Bmp8b, have delayed emergence of the allantoic bud and subsequent 
retardation of allantoic elongation (Ying et al., 2000). Furthermore, inactivation of the Bmp 
signaling intermediate Smad1 results in the absence of allantoic bud in a subset of mutants 
(Lechleider et al., 2001). Mutants for afadin, coding for a component of adherens and tight 
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junctions, also fail to develop the allantois, possibly due to defects in the establishment of 
the outer cell layer within the allantois (Zhadanov et al., 1999).  
Elongation and vascularization of the allantois. 
At headfold stage (e7.75-e8), the allantoic bud grows and elongates through three 
major mechanisms: addition of new cells from the primitive streak, allantoic cell 
proliferation and increase in the intercellular space, a process called cavitation (Brown and 
Papaioannou, 1993; Downs and Bertler, 2000; Tam and Beddington, 1987). At this time, 
mesenchymal cells within the allantois complete the process of de novo vascularisation, in 
which core cells of the allantois differentiate into Flk-1 expressing angioblasts, with a distal 
to proximal polarity. These cells will ultimately undergo endothelial differentiation and 
express the endothelial cell marker PECAM-1. The primary vascular plexus forms along 
the major axis of the allantois and, by 6-8 somite stage (e8.25-e8.5), it amalgamates with 
the developing vasculatures of the embryo and the yolk sac, just below the base of the 
allantois (Downs et al., 1998; Downs et al., 2004; Inman and Downs, 2006).  
Different mouse mutants display defects in allantois enlargement and elongation, 
although the underlying mechanisms remain largely obscure (reviewed in (Inman and 
Downs, 2007)). Many of these mutants belong to the Bmp family, such as Bmp2, Bmp4, 
SMAD1 and SMAD4 mutants (Chang et al., 1999; Downs et al., 2004; Fujiwara et al., 2001; 
Lechleider et al., 2001; Ying and Zhao, 2001; Zhang and Bradley, 1996). Genetic 
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inactivation of the T box transcription factor Tbx4 results in defects in allantoic growth 
associated with apoptosis in the distal allantois (Chapman et al., 1996; Naiche and 
Papaioannou, 2003). Mutants for the homeobox containing transcription factor Cdx2 die 
between e3.5 and e5.5, as Cdx2 function is essential for development of the trophoblast 
lineage. When chimeras were obtained by tetraploid complementation however, Cdx2 
mutants survived until e10, but displayed only a short rudimentary allantois (Beck et al., 
1999; Chawengsaksophak et al., 2004). Another T box transcription factor, brachyury (T) is 
crucial for allantois growth and vascularisation. Different brachyury mutant alleles give rise 
to a short allantois, in which core cells undergo apoptosis and fail to form a functional 
vascular plexus (Gluecksohn-Schoenheimer, 1944; Inman and Downs, 2006). Key factors 
involved in regulating embryonic and yolk sac vascularisation are also expressed in the 
allantois (Downs, 1998; Downs et al., 2004; Dumont et al., 1995). Loss-of-function 
inactivation of Vegf, Flk-1, Flt-1, Tie1 and Tie2 are embryonic lethal due to defective 
vasculogenesis. Surprisingly, no specific defects in allantoic vascularisation were detected 
in these mutants, although this may be because extra-embryonic structures were examined 
only grossly. (Carmeliet et al., 1996; Ferrara et al., 1996; Fong et al., 1995; Hiratsuka et al., 
1998; Hiratsuka et al., 2005; Sato et al., 1995; Shalaby et al., 1995).  
Chorio-allantoic union. 
Once the allantois has enlarged and elongated, at 6-8s embryonic stage (e8.5), it 
reaches the chorionic surface and unites with it. This process requires specific factors 
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produced by both the chorion and the allantois. Grafting experiments have demonstrated 
that chorio-allantoic union is dependent upon the developmental maturity of the allantois, 
while the chorion is always receptive to the allantois (Downs, 1998). The process of chorio-
allantoic union relies in part upon the expression of vascular adhesion molecule 1 (VCAM-
1) and α4-integrin, a binding partner of VCAM-1, expressed in the distal allantois and in 
the chorion, respectively. In mutants for these factors, the allantois forms and elongates, but 
fails to contact the chorion (Gurtner et al., 1995; Kwee et al., 1995; Yang et al., 1995). 
However, in a small proportion of VCAM-1 and α4-integrin mutants, the allantois does 
unite with the chorion, suggesting that other molecular mechanisms are involved in this 
process. Accordingly, a large number of mice mutants show defects in chorio-allantoic 
union, in almost half of the cases, presenting an incompletely penetrant phenotype 
(reviewed in (Inman and Downs, 2007)). For example, in a portion of Cdx2/Cdx4 
compound mutants the allantois fails to attach to the chorion, even if VCAM-1 and α4-
integrin are normally expressed (van Nes et al., 2006).  
Chorion vascularization. 
Once the allantois has contacted the chorion, its distal tip spreads over the chorionic 
surface, probably accompanied by the formation of hydrophobic space in the distal part of 
the allantois. Around e9, the allantoic vasculature starts to invade the chorion and 
simultaneously, the trophoblast surface starts to fold, generating villous structures. This 
process is named chorioallantoic branching morphogenesis (reviewed in (Cross et al., 
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2006)). The sites where the chorionic plate folding occurs and where evagination of the 
allantoic vasculature takes place are marked by the expression of the transcription factor 
Glial cell missing 1 (Gcm1). Gcm1 begins to be expressed in the chorionic plate at e8, and 
during branching of the allantoic vasculature, remains expressed at the distal tip of 
elongating branches. Gcm1 mutants fail to initiate chorioallantoic branching and are 
arrested at a flat chorion stage (Anson-Cartwright et al., 2000).  
Several observations suggest that the process of chorioallantoic branching requires 
close interaction and molecular crosstalk between the trophoblast cell population and the 
allantoic mesoderm and that the fusion of the allantois with the chorion is required to 
trigger important modifications and differentiation in trophoblast stem cells (Cross et al., 
2006). Thus, in various mutants demonstrating impaired chorioallantoic fusion, the 
chorionic plate does not develop villous invaginations and the trophoblast lineage fails to 
properly differentiate.  
Several genes are essential for proper chorioallantoic branching morphogenesis 
(reviewed in (Inman and Downs, 2007; Rossant and Cross, 2001)). Different loss-of-
function mutations affect allantoic vasculature branching. For example, those Cdx2/Cdx4 
compound mutants that successfully undergo chorioallantoic union show decreased 
vascular branching within the labyrinth (van Nes et al., 2006). Various mutants for 
components of the Notch signalling pathway, such as Notch1/Notch4, Hey1/Hey2 and Dll4, 
present a similar phenotype (Duarte et al., 2004; Fischer et al., 2004; Krebs et al., 2000).  
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Many other mutants show impaired vasculogenesis in the labyrinth due to defective 
trophoblast lineage or have defects of unknown origin. However, it is clear that defective 
allantoic or chorionic differentiation can alter the development of surrounding tissue 
complicating the understanding of the defect origin (Rossant and Cross, 2001). 
Prior to e10.5, embryonic development is mainly sustained by diffusion of gases, 
nutrients and waste products through the yolk sac (also referred to as choriovitelline 
placenta). However, after this stage, failure to establish a functional chorioallantoic 
placenta, in which the labyrinthine vasculature is properly branched, is detrimental for 
embryonic survival, leading to mid-gestation lethality due to reduced or impaired exchange 
between the mother and foetus (Rossant and Cross, 2001).  
Figure 1.5 Labyrinth development in the mouse. 
The allantois, the precursor of the umbilical cord, is an epiblast derivative from 
which the labyrinthine vasculature originates. At late neural plate stage, de novo 
vasculogenesis initiates at the distal tip of the allantois. Then the allantois fuses 
with the chorion around e8.5. After chorio-allantoic attachment the vasculature 
of the allantois spreads and branches into the chorion giving origin to the vasculature 
of the labyrinth. Proper branching of the initial chorio-allantoic interface ensures the 
enlargement of the surface for feto-maternal exchanges, which is essential to support 
the increasing metabolism of the growing embryo.
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1.4 Hox gene regulation. 
1.4.1 Hox gene regulation in the primary body axis. 
In the mouse, Hox gene expression in the primary body axis can be subdivided into 
three distinct phases: the initiation of gene expression, the establishment of the definitive 
expression pattern and its subsequent maintenance during later stages of embryonic 
development (Deschamps et al., 1999).  
Initiation of Hox gene expression. 
Hox genes begin to be expressed during gastrulation, at the late streak stage, in cells 
of the posterior primitive streak fated to become extra-embryonic mesoderm. Once 
activated, Hox gene expression domains expand to more anterior levels, up to the node 
region, from where the embryonic primary axis elongates (Deschamps and Wijgerde, 
1993). The timing of its initial activation determines the time at which each Hox gene 
expression domain will reach the node region. However, lineage-tracing experiments 
demonstrated that the definitive Hox expression patterns are not fixed at the node, but will 
be defined later and in more anterior regions (Forlani et al., 2003). The initial activation of 
Hox gene transcription is regulated by events related to the formation and extension of the 
primitive streak, such as Wnt, Fgf and possibly retinoic acid (RA) signalling (Ciruna and 
Rossant, 2001; Forlani et al., 2003; Hogan et al., 1992).  
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Establishment of expression domains. 
Cells leaving the primitive streak early on contribute to future anterior somites, and 
only express 3’Hox genes, while cells leaving the streak later express both 3’ and more 5’ 
Hox genes. However, this early expression program does not correspond to the definitive 
“Hox code” of the descendants of these cells, which will be only fixed later on by 
additional regulatory signals. Initiation, anterior extension and establishment of Hox gene 
expression domains are tightly linked to the emergence, extension and segmentation of the 
body axis (Deschamps and van Nes, 2005). Different factors have been identified as 
possible direct or indirect upstream regulators of Hox genes in both mesoderm and 
neurectoderm derivatives. During axial elongation, cells leaving the node are exposed to 
gradients of Wnt and Fgf signals, both stronger in the posterior embryonic domains 
(Aulehla et al., 2003; Dubrulle et al., 2001), as well as to retinoic acid (RA) gradient, 
stronger in anterior domains (Dubrulle and Pourquie, 2004). In addition, Hox genes may be 
also related to the segmentation of the mesoderm during somitogenesis. Several 3’ Hox 
genes display cyclic transcription in the pre-somitic mesoderm (PSM), correlated to the 
cyclic production of new somites (Zakany et al., 2001). Perturbation of Notch signalling, an 
essential player in the segmentation clock, affects Hox gene expression in the PSM (Zakany 
et al., 2001), or results in a shift in Hox expression domains that produces axial skeletal 
defects (Cordes et al., 2004). RA signalling is also critical in the establishment of Hox 
expression boundaries in the hindbrain (Gavalas and Krumlauf, 2000). RA binds to the 
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intracellular retinoid acid receptor (RAR), which, through heterodimerization with the 
retinoid X receptor (RXR), binds to retinoid acid response elements (RAREs). Such 
elements were identified in the vicinity of group 1 to 4 Hox genes, and are required for 
appropriate Hox expression in rhombomeres, indicating that RA directly regulates Hox 
gene expression (e.g. (Dupe et al., 1997; Marshall et al., 1994; Studer et al., 1994). In the 
hindbrain, cross-interaction between Hox genes and the transcription factors Krox20 and 
Kreisler have been shown to establish the definitive expression patterns for 3’ Hox genes 
(Manzanares et al., 1999; Manzanares et al., 1997; Manzanares et al., 2002; Nonchev et al., 
1996; Sham et al., 1993). The 3’ Hox expression in the hindbrain also involves auto- and 
cross-regulatory loops that are presumably involved in the maintenance and reinforcement 
of Hox gene expression (Gould et al., 1997; Maconochie et al., 1997; Manzanares et al., 
2001; Packer et al., 1998; Popperl et al., 1995; Studer et al., 1994).  
Other key regulators of Hox genes in the establishment of the AP patterning are 
genes of the Cdx family of transcription factors. Cdx genes are homologous to the 
Drosophila caudal gene and are closely related to Hox genes, as they are believed to derive 
from the same common ancestral ProtoHox cluster (Pollard and Holland, 2000). The Cdx 
family is composed of three members: Cdx1, Cdx2 and Cdx4. During early embryonic 
development, these genes are expressed similarly to Hox genes, with nested expression 
domains along the AP axis (reviewed in (Young and Deschamps, 2009)). Cdx mutants 
display vertebral patterning defects, correlating with perturbation of the “Hox code” from 
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cervical to caudal levels (Houle et al., 2003; van den Akker et al., 2002). Moreover, Cdx 
proteins can directly regulate Hox gene expression, via Cdx binding sites that are found 
clustered in the Hox clusters (Charite et al., 1998; Subramanian et al., 1995). Cdx genes are 
regulated by Wnt, Fgf and RA signalling, and it was proposed that they convey these 
signals to Hox genes (Lohnes, 2003).  
Along with these molecular interactions of transcription factors and signalling 
pathways, the sequential transcriptional activation of Hox genes during early embryonic 
development, as well as in the differentiation of ES cells in vitro, is accompanied by higher 
order chromatin dynamics (reviewed in (Soshnikova and Duboule, 2009a; Sproul et al., 
2005)). Activating and repressive histone marks, such as trimethylation at lysine 4 or 
trimethylation at lysine 27 as well as acetylation at lysine 9 of histone H3, follow inverse 
temporal collinear changes in their distribution from 3’ to 5’ of the cluster (Chambeyron 
and Bickmore, 2004; Soshnikova and Duboule, 2009b). These chromatin modifications 
precede the actual Hox gene activation. However, the histone mark distribution is largely 
preserved even in presence of a split Hox cluster, ruling out the existence of a spreading 
mechanism of these chromatin modifications (Soshnikova and Duboule, 2009b). Mutations 
in Polycomb group genes, that code for the enzymatic complexes that deposit these marks, 
result in heterochronies in Hox gene activation, confirming a functional role of these 
chromatin modifications (Bel-Vialar et al., 2000). Furthermore, experiments performed 
both in differentiating ES cells as well as in embryonic tissues demonstrate that the overall 
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DNA organization changes during gene collinear transcriptional activation, and inactive 
and active genes are localized in distinct three-dimensional domains of the nucleus 
(Chambeyron et al., 2005; Morey et al., 2007; Noordermeer et al., 2011).  
Once Hox genes are activated, the correct anterior limit of expression for each of 
them has to be established. As the vertebrate body extends by posterior growth, it was 
proposed that the temporal progression of Hox gene activation, along with axis elongation, 
could directly determine the establishment of the anterior limit of expression at later stages 
(Duboule, 1994). In chicken embryos, over-expression of 5’ Hox genes in epiblast cells 
delay their ingression through the primitive streak, modifying the final axial position they 
contribute to (Iimura and Pourquie, 2006). However, mice with engineered heterochronies 
in gene activation do not systematically show altered anterior limit of gene expression, 
suggesting the existence of multiple superimposed regulatory mechanisms underlying 
temporal Hox gene activation in the trunk (Kondo and Duboule, 1999; Tschopp et al., 2009; 
van der Hoeven et al., 1996). In the recent model for HoxD regulation in the trunk, the 
initiation of the temporal collinear gene activation is under the control of a centromeric-
located repressive influence and a telomeric- based activation mechanism, thus the time of 
activation of each gene is dependent on its location within the cluster. The final spatial 
localization of Hox transcripts, in contrast, seems to rely largely on local regulatory 
elements acting at short distance and located inside the cluster (Tschopp et al., 2009).  
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Maintenance of gene expression. 
Polycomb group (PcG) and Trithorax group (TrxG) genes were first identified in 
Drosophila where, when mutated, give rise to homeotic transformations. They play a key 
role in preserving Hox gene expression once the expression domains are established 
(reviewed in (Maeda and Karch, 2006; Ringrose and Paro, 2007)). PcG and TrxG gene 
function is largely conserved between Drosophila and vertebrates (Gould, 1997). Both gene 
groups code for proteins involved in epigenetic modification of the chromatin at specific 
sites, via histone modifications that are inherited after cell division. These enzymes, in 
addition to their function on Hox clusters, also regulate the chromatin state at many other 
genomic loci. PcG genes are required to maintain Hox genes in a silent state outside their 
normal expression domains, while TrxG genes are essential for maintenance of Hox gene 
expression. Both groups bind as multiprotein complexes to cis regulatory elements located 
in the proximity of target gene promoters. Some PcG complexes were shown to promote 
trimethylation of lysine 27 of histone H3, while TrxG complexes promote trimethylation of 
lysine of the same histone (Byrd and Shearn, 2003; Cao and Zhang, 2004). These histone 
modifications usually correlate with silent or active transcriptional states genome-wide, 
however how exactly they affect transcription remains to be determined.  
In the mouse, PcG mutations lead to anteriorization of Hox gene expression causing 
posterior homeotic transformations, as for instance in the case of Bmi1, mel18, M33 or Eed 
mutants (Akasaka et al., 1996; Core et al., 1997; van der Lugt et al., 1996; van der Lugt et 
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al., 1994; Wang et al., 2002). Conversely, inactivation of the TrxG gene Mll does not 
interfere with gene activation, but leads to subsequent loss of Hox expression (Yu et al., 
1998; Yu et al., 1995).  
1.4.2 Local cis-regulatory elements and regulatory landscapes.  
Hox gene transcriptional regulation, in both time and space, apparently relies on the 
complex interaction of many different regulatory mechanisms at work in cis. Different 
mechanisms of regulation are likely to be at work both at the gene and cluster level. 
Spatiotemporal collinearity is the result of a balanced interaction between intrinsic 
regulatory elements and mechanisms of global regulation ((Spitz and Duboule, 2008)).  
Cis- regulatory elements are non coding DNA sequences that modulate gene 
activity, through both activation and repression of transcription, and can be located in the 
immediate vicinity of target gene promoters or in remote locations, up to 1 Mb distance 
from their targets (reviewed e.g. (Ong and Corces, 2011) (Kleinjan et al., 2001; Lettice et 
al., 2003)). Recently developed techniques, such as chromosome conformation capture (3C) 
and its variants, have allowed the spatial organization of DNA loci in vivo to be directly 
addressed (Gavrilov et al., 2009).  The results obtained strongly suggest that gene 
regulation at such genomic distance is achieved by the formation of chromatin loops that 
bring distant regulatory elements into close proximity with target promoters (reviewed e.g. 
(Ong and Corces, 2011)).  
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In the main body axis, important aspects of the spatial Hox transcript distribution 
can be explained by the action of local and short-range regulatory elements. In fact, when 
randomly integrated into the genome, most of the larger transgenes were able to 
recapitulate Hox-like expression patterns in the trunk (Charite et al., 1995; Whiting et al., 
1991; Zakany et al., 1988), but not in more recently evolved structures, like the limbs and 
genitals (Gerard et al., 1993; Renucci et al., 1992). These expression patterns were only 
recovered when the same transgenes were targeted in the context of their endogenous 
cluster environment (Spitz et al., 2001; van der Hoeven et al., 1996). Subsequent 
experiments demonstrated that the expression of Hox genes in evolutionarily more recent 
structures, like the digits and genitals, depends on global enhancer elements located in 
regions considerably distant from the cluster (reviewed in (Spitz and Duboule, 2008)).  
Substantial efforts have been used to shed light on the regulatory mechanisms associated 
with Hox gene expression during limbs development, as a paradigm for the emergence of 
evolutionary innovations. A transgenic approach involving large, randomly tagged BACs 
covering the region 5’ to the HoxD cluster, identified a segment of about 40 kb, referred to 
as global control region (GCR). The GCR lies around 200 kb from Hoxd13 and is able to 
drive reporter expression in the limbs and genitals (Spitz et al., 2003). The limb enhancer 
activity was subsequently assigned to a 5 kb highly conserved fragment (region B 
(Gonzalez et al., 2007)). However, the GCR alone is not able to fully recapitulate the 
endogenous Hoxd gene expression in limbs. Another region, Prox, which was subsequently 
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identified approximately 50 kb upstream to Hoxd13, also drives reporter expression in 
limbs when directly linked to the reporter, but is not able to activate Hoxd genes at a 
distance in transgenic assays (Gonzalez et al., 2007). Interestingly, even if they display 
different patterns, when linked together in a reporter transgene, GCR and Prox show 
synergistic activity, resulting in a more bona fide recapitulation of endogenous 5’Hoxd 
gene expression (Gonzalez et al., 2007). Moreover, a transgene including GCR linked to a 
human BAC including Prox and posterior HoxD cluster is able to partially rescue the limb 
phenotype associated with a lack of 5’ Hoxd genes (Gonzalez et al., 2007). Thus, global 
regulatory mechanisms mediate the expression of 5’Hoxd and neighboring genes such as 
Evx2 and Lnp in the developing limbs and genitalia and rely on at least two distinct 
enhancers located upstream of the HoxD cluster. A similar situation was also described at 
the HoxA locus, as Hoxa13 also seems to be part of a regulatory landscape with Evx1 and 
other genes located further away in the chromosome showing expression in limb and 
genitalia (Lehoczky et al., 2004). Moreover, a sequence showing high conservation with 
region B was identified in the vicinity of Evx1, but failed to drive clear reporter expression 
in limbs in transgenic assays (Lehoczky et al., 2004).  Experiments based on tagged BAC 
transgenes suggest that at least two elements centromeric to Evx1 are able to partially 
recapitulate endogenous Hoxa expression in limbs and genitals (Lehoczky and Innis, 2008), 
however proof that these sequences are bona fide regulatory elements for Hoxa genes has 
not been provided.  
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Similarly, evidence suggests that an element responsible for Hoxd gene expression 
in the early limb bud and the intestinal hernia (ELCR) is located on the opposite side of the 
HoxD cluster (Zakany et al., 2004). The trans-allelic targeted meiotic recombination 
technique (TAMERE) (Herault et al., 1998) enabled experiments determining that in the 
early limb buds, the temporal sequence of Hoxd gene expression is controlled by their 
position relative to the 3’ extremity of the cluster. The restriction of posterior gene 
expression to the posterior part of the limb bud, in contrast, is dependent on the gene 
position relative to the 5’ extremity, which exerts a repressive effect (Tarchini and 
Duboule, 2006). Interestingly, a similar mechanism underlies Hoxd gene expression in the 
trunk at early stages of embryonic development (Tschopp et al., 2009). Such a dependence 
of expression territory on the genomic configuration of the complex was illustrated by the 
changes in Hoxd gene expression caused by Sequential Targeted Recombination INduced 
Genomic rearrangement (STRING)-generated inversions of large DNA regions flanking the 
HoxD cluster and by a 3 Mb inversion resulting in the split of the HoxD cluster in two sub-
clusters (Spitz et al., 2005).  
A wealth of data obtained in the last 15 years therefore describe a picture in which 
important parts of the ancient Hox regulatory system are located within the cluster, while 
novel regulatory elements lie outside it, in large regulatory landscapes. This arrangement 
likely came about to avoid interference with control elements related to ancestral Hox 
functions (Fig. 1.6).  
Figure 1.6 The global regulatory organization of the murine HoxD locus. 
Regulatory elements responsible for setting up spatial collinearity in the primary 
body axis are mostly located within the gene cluster itself (blue). Expression 
specificities in more recently evolved embryonic structures are driven by enhancer 
elements residing in the flanking gene deserts. This is the case, for example, for the 
distal limb bud and the genitalia, with the responsible regulatory elements located on 
the centromeric side (yellow), whereas enhancers driving Hoxd gene expression in 
the proximal limb and the intestinal hernia are found on the telomeric side (green).
 (Tschopp and Duboule, 2011)
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Aim of the thesis. 
In the last two decades evidence was obtained suggesting that Hox genes have been 
co-opted for the patterning of evolutionary novel embryonic structures such as limbs and 
external genitalia. Growing evidence suggest that the recruitment of Hox genes to achieve 
additional functions relies largely upon the acquisition of novel regulatory mechanisms, 
distinct from the ones already at work in the trunk.  
Recent studies have shown that the most 5’ genes of the HoxA cluster, namely 
Hoxa13, is functional not only in the embryo proper, where it is required for proper limb 
and urogenital development, but is also essential in the extra-embryonic compartment, for 
the proper expansion of the vasculature within the placental labyrinth. Inactivation of 
Hoxa13 leads, in fact, to embryonic lethality due to impaired feto-maternal exchanges. This 
suggests that the recruitment of Hoxa13 in the extra-embryonic tissues might have been 
pivotal for the evolution of developmental strategies associated with the emergence of 
placental species.  
The goal of my doctoral studies was to better understand the regulatory mechanisms 
underlying Hoxa13 recruitment in the extra-embryonic compartment. Using expression 
analysis, genetic rearrangements and transgenic analysis I investigated whether Hoxa 
function in the extra-embryonic compartment is restricted to Hoxa13 and I explored the 
regulatory mechanisms underlying Hoxa13 expression in the extra-embryonic tissues. 
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Moreover, through the analysis of Hoxa gene expression in a non-placental species, I tried 
to ascertain the point of vertebrate evolution at which Hox genes were recruited to the 
extra-embryonic compartment. Finally, the generation of a new genetic tool allowed me to 
perform genetic lineage-tracing analyses to help understanding the overall Hoxa13 
contribution to embryonic and extra-embryonic structures.  
 
  
Chapter 2 
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2.2 Abstract:  
The Hox gene family is well known for its functions in establishing morphological 
diversity along the anterior-posterior axis of developing embryos. In mammals, one of 
these genes, namely Hoxa13, is critical for embryonic survival as its function is required for 
the proper expansion of the fetal vasculature in the placenta. Thus it appears that the 
developmental strategy specific to placental mammals is linked, at least in part, to the 
recruitment of Hoxa13 function in developing extra-embryonic tissues. Yet, the mechanism 
underlying this extra-embryonic recruitment is unknown. Here we provide evidence that 
this functional novelty is not exclusive to Hoxa13 but shared with its neighboring Hoxa11 
and Hoxa10 genes. We show that the extra-embryonic function of these three Hoxa genes 
stems from their specific expression in the allantois, an extra-embryonic hallmark of 
amniote vertebrates. Interestingly, Hoxa10-13 expression in the allantois is conserved in 
chick embryos, which are non-placental amniotes, suggesting that the extra-embryonic 
recruitment of Hoxa10, Hoxa11 and Hoxa13 most likely arose in amniotes, i.e. prior to the 
emergence of placental mammals. Finally, using a series of targeted recombination and 
transgenic assays, we provide evidence that the regulatory mechanism underlying Hoxa 
expression in the allantois is extremely complex and relies on several cis-regulatory 
sequences. 
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2.3 Introduction : 
The Hox gene family is well known for its major role, conserved throughout the 
animal kingdom, in the establishment of the body architecture during embryogenesis 
(Kmita and Duboule, 2003; Krumlauf, 1994; Young and Deschamps, 2009). In addition to 
this ancestral function, Hox genes have been recruited in the course of evolution to achieve 
a variety of different functions, including the morphogenesis of evolutionarily novel 
structures (Pearson et al., 2005). The genome of most vertebrates contains 39 Hox genes 
physically grouped into four clusters, referred to as HoxA, HoxB, HoxC and HoxD clusters. 
Individual inactivation of the various Hox genes revealed that Hoxa13 is the only member 
of this gene family required for embryonic survival (Fromental-Ramain et al., 1996b; Shaut 
et al., 2008; Stadler et al., 2001). Accordingly, mutants carrying deletion of the HoxB, 
HoxC or HoxD cluster are viable, at least until birth (Medina-Martinez et al., 2000; Spitz et 
al., 2001; Suemori and Noguchi, 2000). The lethality of Hoxa13-/- embryos is due to 
impaired expansion of the fetal vasculature in the placental labyrinth, which precludes 
adequate exchanges between maternal and fetal blood to ensure embryonic survival (Shaut 
et al., 2008). Thus, at least in mice, the function of Hoxa13 is not restricted to the embryo 
proper. Importantly, it also suggests that the function of Hoxa13 may have played a critical 
role in the emergence of the developmental strategy characterizing placental mammals. In 
this study we have addressed two key questions relevant to this role: how Hoxa13 has been 
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recruited in the extra-embryonic compartment and is this recruitment restricted to placental 
vertebrates? 
We present evidence that Hoxa10 and Hoxa11, the closest neighboring genes to 
Hoxa13, also contributes to the proper formation of the labyrinthine vasculature indicating 
that extra-embryonic recruitment is not restricted to Hoxa13. We show that the extra-
embryonic function of these 5’Hoxa genes is linked to their expression in the allantois, a 
mesoderm derivative of the posterior primitive streak and hallmark of amniote embryos 
(Downs, 2009). Interestingly, we found that 5’Hoxa genes are also expressed in the 
allantois of a non-placental amniote suggesting that the extra-embryonic recruitment of 
5’Hoxa genes predates the emergence of placental vertebrates. Finally, our work reveals a 
specific transcriptional control underlying 5’Hoxa extra-embryonic expression and we 
propose that the emergence of the reproductive strategy of placental species was tightly 
linked to the evolution of Hoxa gene regulation. 
2.4 Results:  
2.4.1 Hoxa10 and Hoxa11 together with Hoxa13 contribute to 
the development of the labyrinthine vasculature. 
Inactivation of individual Hox genes in mice has revealed that Hoxa13 is the only 
member whose function is required for embryonic survival (Fromental-Ramain et al., 
1996b; Shaut et al., 2008). Unexpectedly, while live Hoxa13-/- embryos can be recovered 
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at embryonic day (e) 14.5 (Fromental-Ramain et al., 1996b; Shaut et al., 2008), we found 
that embryos homozygous for the deletion of the entire HoxA cluster (referred to as 
HoxAdel/del hereafter) do not survive later than e12. As mid-gestation lethality is typically 
related to cardio-vascular and/or placental defects (Copp, 1995) and mortality of Hoxa13-/- 
embryos is associated with placental dysfunction (Shaut et al., 2008), we hypothesized that 
the early lethality of HoxAdel/del mutants is the consequence of an exacerbated placental 
defect as compared to the single Hoxa13 inactivation. Consistent with this assumption, 
abnormal placental morphology and marked reduction of the endothelium within the 
labyrinth is observed in all e10.5 HoxAdel/del placentas analyzed (Fig. 2.1), while Hoxa13-
/- placenta remains undistinguishable from wild type specimens until e11.5 (Shaut et al., 
2008). Previous studies identified the requirement of Hoxa10 and Hoxa11 for the proper 
function of the uterus (Benson et al., 1996; Gendron et al., 1997; Satokata et al., 1995) 
raising the possibility that the more severe phenotype of HoxAdel/del placenta could be due 
to a combination of loss of Hoxa13 function in the labyrinth and reduced HoxA dosage in 
the mother’s uterus. However, epiblast-specific conditional inactivation of the HoxA 
cluster, using the HoxAflox mice (Kmita et al., 2005) and the mox2Cre deleter strain 
(Tallquist and Soriano, 2000), resulted in the same placental phenotype as HoxAdel/del 
mutants (not shown) indicating that this phenotype is due to the loss of Hoxa genes in 
epiblast derivatives. 
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The vasculature of the labyrinth originates from the allantois (Inman and Downs, 
2007; Rossant and Cross, 2001), a mesoderm derivative of the posterior primitive streak 
(Downs et al., 2004; Kinder et al., 1999; Lawson, 1999). Allantoic vascularization occurs 
de novo similarly to the embryo and yolk sac vascularization (Downs et al., 1998; Drake 
and Fleming, 2000).  Following the beginning of vasculogenesis, the distal tip of the 
allantois fuses to the chorion and subsequent expansion of the distal allantoic vascular 
plexus within the chorionic plate gives rise to the fetal vasculature of the labyrinth (Inman 
and Downs, 2007; Rossant and Cross, 2001). To establish which Hoxa genes are involved 
in the development of the labyrinthine vasculature, we analyzed the expression of all Hoxa 
genes starting at allantoic bud-stage (e.7.5). As shown in figure 2.2, Hoxa13 is expressed in 
the allantois together with its closest neighbors, Hoxa10 and Hoxa11, both prior to and 
after chorio-allantoic fusion. Unexpectedly, this co-expression is transient and by e9.5 the 
extra-embryonic expression of Hoxa10 and Hoxa11 is only detected in the maternal part 
(decidua) and not in the labyrinth (Fig.2.2 and Fig. S2.1).  
2.4.2 5’Hoxa genes are expressed in progenitors of the 
labyrinthine vasculature. 
The early and transient co-expression of 5’Hoxa genes suggests that the precocious 
vascular defect in HoxAdel/del placenta, when compared to the single Hoxa13 loss of 
function, is due to the combined 5’Hoxa inactivation in the allantois and/or nascent chorio-
allantoic interface. However, at the stage of chorio-allantois fusion, there is no apparent 
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reduction of the endothelial cell population in HoxAdel/del allantois (Fig. S2.2), thereby 
excluding impaired endothelial differentiation and/or expansion in the allantois as a cause 
for the labyrinthine phenotype. In turn, this result raises the possibility that 5’Hoxa 
expression actually occurs in progenitor cells of the labyrinthine vasculature but its 
functional outcome is only detectable at later stages of labyrinth development. In an attempt 
to clarify this issue, we investigated the fate of the allantoic cells expressing these genes. 
For this purpose, we used a mouse line driving expression of the Cre recombinase in all 
cells in which Hoxa13 is normally expressed such that, in presence of a Cre reporter 
transgene, Hoxa13-expressing cells and their descendants permanently express the reporter 
transgene. As genetic fate mapping is a three step-process (activation of Cre transcription, 
recombination of the reporter transgene and synthesis of the reporter protein), we first 
established the delay existing between Cre transcriptional activation (i.e. Hoxa13 
activation) and the actual expression of the reporter protein. We found that the reporter 
protein is detectable 20-24h after the initial Cre transcription (not shown). To verify that 
the Hoxa13Cre allele is functional in all cells normally expressing Hoxa13, we first looked 
at Cre-reporter expression in developing limbs, where Hoxa13 has been extensively studied 
and where, as in the allantois, its transcriptional activation occurs in mesenchymal cells. 
One day after Hoxa13 transcriptional activation, Cre reporter expression is found in all 
mesenchymal cells of distal limb buds (Fig. S2.3A-B), providing evidence that our 
Hoxa13Cre allele is an efficient tool for tracing the fate of Hoxa13-expressing cells.  
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In the allantois, reporter expression is first detected at e8.25 (Fig. 2.3B), consistent 
with the delay existing between Cre transcriptional activation and Cre-mediated 
recombination, such that reporter expression at e8.25-8.5 highlights the fate of the first 
Hoxa13 expressing cells and their progeny (referred to as Hoxa13lin+ cells hereafter). 
Interestingly, while Hoxa13 is predominantly expressed in the proximal domain of the 
allantois at e7.5 (Fig. 2.3A), at e8.25-8.5 a large proportion of Hoxa13lin+ cells are located 
at the chorio-allantoic interface/nascent labyrinth and only few Hoxa13lin+ cells are found 
in the proximal allantois (Fig. 2.3B). This early fate-map indicates that a significant subset 
of cells in which Hoxa13 is initially activated contributes to the formation of the labyrinth. 
Surprisingly, at e8.5, virtually none of theses cells are of endothelial identity as revealed by 
co-immunostaining for the platelet endothelial cell adhesion molecule 1 (PECAM-1 also 
known as CD31, Fig. 2.3C-E). However, the proportion of Hoxa13lin+ cells expressing the 
endothelial marker CD31 (Hoxa13lin+/CD31+) increases progressively during 
embryogenesis (Fig. 2.4) and at late gestation, all Hoxa13lin+ cells are part of the fetal 
vasculature in the labyrinth, forming the labyrinthine endothelium as well as vascular 
smooth muscles that surround larger blood vessels at the base of the labyrinth (Fig. 2.4 and 
not shown). Consistent with the pool of Hoxa13lin-/CD31+ cells in the nascent labyrinth 
and undetectable Hoxa13 expression beyond e9, the endothelium in the mature labyrinth is 
formed of both Hoxa13lin positive and negative cells (Fig. S 2.3C-E). In marked contrast, 
the endothelium of the mature umbilical cord is completely deprived of Hoxa13lin+ cells, 
which are found exclusively adjacent to the endothelium and forming vascular smooth 
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muscles (Fig. 2.4J-L). Together these results show that endothelial differentiation of 
Hoxa13lin+ cells takes place exclusively in the labyrinth and suggest that the ultimate fate 
of this cell population is influenced by extrinsic factors. However, Hoxa13 appears 
dispensable for endothelial differentiation as the fate map of Hoxa13-expressing cells in 
absence of Hoxa13 protein shows that Hoxa13lin+ cell population is reduced but remains 
capable of differentiating into endothelial cells (Fig. S2.4) 
2.4.3 Expression of 5’Hoxa genes in the allantois is required for 
embryonic survival. 
Our fate map and in situ data suggest that 5’Hoxa function in proper expansion of 
the labyrinthine endothelium is associated with their expression in endothelial cell 
progenitors initially located in the allantois. As a consequence, gene inactivation after e8.5 
should have little or no effect on the development of the labyrinthine vasculature. To 
identify the temporal requirement of 5’Hoxa function, we took advantage of the spatial and 
temporal specificity of the Hoxa13Cre allele. Since Hoxa13 coding sequence is disrupted in 
the Hoxa13Cre allele, we generated Hoxa13Cre/HoxAflox mutants in which Hoxa13 
inactivation occurs in all cells normally expressing Hoxa13 but with the 20 to 24h delay 
inherent to the Cre-mediated recombination. We found that Hoxa13Cre/HoxAflox mutants 
are fully viable and accordingly the vasculature of Hoxa13Cre/HoxAflox labyrinth is 
undistinguishable from that of wild type specimens (Fig. 2.5A-C). This conditional 
inactivation has a drastically distinct effect on limb development, during which Hoxa13 
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expression is detectable over several days. Indeed, Hoxa13Cre/HoxAflox mice exhibit limb 
defects (Fig. 2.5D-E) reminiscent of the phenotype associated with complete Hoxa13 
inactivation (Perez et al., 2010), thereby demonstrating the efficiency of Hoxa13Cre-
mediated inactivation of the HoxAflox allele. Together, these results provide evidence that 
transient Hoxa13 expression in the allantois is sufficient to ensure proper vasculature 
development in Hoxa13Cre/HoxAflox labyrinth and survival of the embryo. Thus, 
expression of Hoxa13 in the allantois up to chorio-allantoic fusion stage is key for proper 
function of the placental labyrinth. 
2.4.4 Extra-embryonic recruitment of 5’Hoxa genes is specific to 
the allantois and is not restricted to placental mammals. 
The placental phenotype of both Hoxa13-/- and HoxAdel/del mutants (Shaut et al., 
2008; this study) provides evidence that 5’Hoxa genes play a key role in the proper 
formation of the labyrinthine vasculature. In contrast, the vasculature in mutant and wild 
type yolk sacs is indistinguishable (Fig. S 2.5A-D). Accordingly, analysis of Hoxa13Cre/+; 
Rosa26R conceptus shows that Hoxa13lin+ cells do not contribute to the formation of the 
yolk sac (Fig. S 2.5E), thus indicating that the extra-embryonic recruitment of Hoxa genes 
is specific to the allantois and its derivatives. Since the allantois is an extra-embryonic 
hallmark of amniote vertebrates, the recruitment of 5’Hoxa genes in this tissue could have 
arisen prior to the emergence of placental species. To test this possibility, we investigated 
Hoxa expression in chick embryos. In this non-placental amniote, 5’Hoxa genes are also 
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specifically expressed in the allantois (Fig. 2.6A) indicating that extra-embryonic 
recruitment of 5’Hoxa genes is not restricted to placental species. Previous studies revealed 
that the allantois is a mesoderm derivative of the posterior primitive streak that buds and 
extends into the exocoelom (Downs et al., 2004; Kinder et al., 1999; Lawson, 1999). 
Knowing that vertebrate Hox genes are activated in epiblast cells prior to ingression 
through the primitive streak (Iimura and Pourquie, 2006), the possibility exists that the 
extra-embryonic expression of 5’Hoxa genes is a mere collateral effect of the emergence of 
the allantois, i.e activation of 5’Hoxa genes in the epiblast prior to formation of the 
epiblast-derived “appendage” into the exocoelom. However, at early stages, 
Hoxa13lin+cells are located exclusively in the extra-embryonic compartment (Fig. 2.4A) 
indicating that the initial activation of 5’Hoxa genes occurs in epiblast-derived cells only 
once these cells are already engaged in the extra-embryonic fate. This specificity suggests 
that the activation of 5’Hoxa genes in the allantois is most likely independent of the 
mechanism underlying initial Hox activation in the embryo proper.  
2.4.5 The transcriptional control of 5’Hoxa genes in the allantois 
involves an enhancer-sharing mechanism. 
To gain insights into the mechanism underlying the recruitment of 5’Hoxa genes in 
the allantois, we next investigated whether it is linked to particular features of 5’Hoxa 
promoters or associated with an enhancer-sharing mechanism. To address this issue, we 
first investigated the expression of the transgene located at the 5’end of the HoxA cluster in 
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HoxAflox embryos. This transgene, located 3.5kb away from Hoxa13, contains the 
housekeeping phosphoglycerate kinase-1 (PGK) promoter, previously shown to respond to 
enhancer activity spanning the transgene insertion site (Herault et al., 1999). When 
randomly inserted or targeted at the 5’ end of the HoxD cluster, this promoter has no 
detectable activity in the allantois (Kmita et al., 2000b). In contrast, when targeted to the 5’ 
end of the HoxA cluster, it becomes robustly expressed in the allantois (Fig. 2.6C) revealing 
the existence of an “allantois” enhancer whose activity is shared between neighboring 
genes. Interestingly, this locus-specific expression persists in absence of the HoxA cluster 
(Fig. 2.6D) suggesting that the enhancer is located outside the HoxA cluster. Yet, Evx1, the 
closest 5’Hoxa neighboring gene outside the HoxA cluster, is not expressed in the allantois 
(Fig. 2.6E), raising the possibility that the “allantois” enhancer is located within the 
Hoxa13-Evx1 intergenic region but in the vicinity of Hoxa13. To test this hypothesis, we 
first generated transgenic mice carrying this 50kb region linked to the lacZ reporter gene 
(IR50 in Fig. 2.6F). Out of five independent lines, one fails to express the reporter but the 
four other lines show lacZ expression in the allantois as well as chorio-allantoic interface at 
e8.5 (Fig. 2.6F). Interestingly, at e9, the transgene is not expressed in the labyrinth and 
becomes downregulated in the allantois (Fig. 2.6F and not shown), reminiscent of the 
5’Hoxa expression pattern. Together these results show that the Hoxa13-Evx1 intergenic 
region contains a regulatory element capable of activating gene expression in the allantois. 
To test whether this element is necessary and sufficient to drive the expression of 5’Hoxa 
genes in the allantois, we next analyzed the impact of deleting the endogenous Hoxa13-
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Evx1 intergenic region. Unexpectedly, expression of 5’Hoxa genes and the PGK-transgene 
remain detectable in the allantois of homozygous embryos carrying this deletion (Del5, Fig. 
2.7) indicating the existence of additional regulatory element(s) underlying 5’Hoxa 
expression in the allantois. Accordingly, Del5 homozygous embryos survive until birth. 
The presence of a transcriptional enhancer in the Hoxa13-Evx1 intergenic region 
raises the possibility that the recruitment of 5’Hoxa genes in the allantois originates from 
the appearance of an evolutionary novel transcriptional regulatory element. Alternatively, 
this element could have been already functional in another tissue prior the emergence of 
amniotes and the presence of appropriate transcription factors in the allantois resulted in its 
functional co-option therein. Analysis of our IR50 transgenic lines shows that the Hoxa13-
Evx1 intergenic region triggers also reporter gene expression in the tail bud and developing 
limbs (Fig. S 2.6, top), two domains where 5’Hoxa genes are expressed. In an attempt to 
assess whether these expression domains rely on distinct or shared regulatory elements, we 
subdivided the 50kb intergenic region into smaller DNA fragments, each one linked to the 
lacZ reporter gene driven by the b-globin minimal promoter (referred to as b-lacZ). To 
avoid variations in transgene expression due to position effects, each transgene was flanked 
with the H19 insulator sequence. We generated 12 distinct transgenes (named “a” to “l” in 
Fig. S 2.6) and for each of them, we analyzed at least five transgenic embryos at e8.5 and at 
least three at e12.5 (see supplementary table 1). At e12.5, four of these transgenes trigger 
lacZ expression (Fig. S 2.6, transgenes # c, f, g and l). Three of them show staining in limbs 
(Fig. S 2.6, #c, f, g) that recapitulates partially the IR50 expression pattern. We next 
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analyzed these transgenes at e8.5 and did not detect any b-Gal staining, except for embryos 
carrying the transgene “l”, in which staining is observed in the midbrain (not shown). These 
results suggest that regulatory elements capable of triggering gene expression in limbs are 
not functional in the allantois. We then tested expression of the eight other transgenes at 
e8.5 but strikingly none of them shows expression in the allantois or tail bud. Consistent 
with the lack of tail bud expression at e8.5, none of the e12.5 transgenic embryos express 
the lacZ reporter in the developing tail (Fig. S 2.6). Together these results show that, while 
the entire Hoxa13-Evx1 intergenic region results in reporter expression in the allantois, tail 
bud and developing limbs, sub-domains of this DNA fragment are only able to trigger 
reporter expression in limb buds when assayed individually.  
2.5 Discussion.  
The embryonic lethality resulting from impaired vascular development in the 
labyrinth of Hoxa13 mutant revealed that in mice, and possibly other vertebrate species, the 
function of Hox genes is not restricted to the embryo proper. This discovery raises the 
question of the evolutionary history underlying the extra-embryonic recruitment of Hoxa13. 
In this study, we used a combination of targeted genomic rearrangements, transgenesis and 
genetic fate mapping to gain insights into the transcriptional regulation underlying Hoxa13 
function in the placental labyrinth. The expression data, genetic fate mapping and 
conditional gene inactivation presented here further reveal that the primary extra-embryonic 
function of Hoxa13 relies on its expression in a subset of cells forming the allantois, well 
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before defects in the labyrinthine vasculature are detectable in Hoxa13-/- mutant. 
Interestingly, Cdx function in labyrinth development also relies on their expression in 
endothelial progenitors in the allantois (van Nes et al., 2006; Young et al., 2009) and 
reduced Cdx dosage results in a phenotype similar to that of HoxAdel/del labyrinth. Such 
similarity between Cdx and Hox mutants is consistent with the role of Cdx proteins as 
regulators of Hox genes, as illustrated for some Hox genes during anterior-posterior 
patterning of the axial skeleton (reviewed in e.g (Young and Deschamps, 2009) and 
suggests that the role of Cdx genes in proper labyrinth formation is mediated, at least in 
part, by Hox genes. While the allantois contains progenitor cells of both labyrinthine and 
umbilical cord endothelium, those expressing Hoxa13 do not contribute to the umbilical 
cord endothelium. This specificity could be explained by a cell non-autonomous effect, 
whereby signaling from trophoblast cells would be required for endothelial differentiation 
of Hoxa13-expressing cells and their descendants. Consistent with this hypothesis, 
evidence has been obtained that cross-talks between trophoblast and allantois cells play a 
key role in the development of the fetal vasculature in the labyrinth (Rossant and Cross, 
2001). Noteworthy, recent analysis of the fate map of Tbx4-expressing cells provided 
evidence for a key role of peri-vascular cells during vasculogenesis in the allantois (Naiche 
et al., 2011). However, in contrast to Tbx4 (Naiche and Papaioannou, 2003), Hoxa13 is 
dispensable for endothelial differentiation. Instead our fate map shows reduced Hoxa13lin+ 
cell population in Hoxa13-/- labyrinth, consistent with decreased expansion of the 
endothelial network.  
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The downregulation of Tie2, Foxf1 and autotaxin (Enpp2), which are Hoxa13 target 
genes (McCabe and Innis, 2005; Shaut et al., 2008), was proposed to account for the 
reduced fetal vasculature in Hoxa13-/- labyrinth (Shaut et al., 2008). The function autotaxin 
and Foxf1 is actually required in the allantois where their inactivation prevents chorio-
allantoic fusion and de novo vasculogenesis (Mahlapuu et al., 2001; van Meeteren et al., 
2006). Our finding that cells forming the endothelium of the allantois/umbilical cord 
originate from cells in which Hoxa13 is never expressed thus provides an explanation for 
proper formation of the endothelium in Hoxa13-/- allantois/umbilical cord. Nonetheless, 
this does not exclude that down-regulation of autotaxin and/or Foxf1 in Hoxa13-expressing 
cells affects the development of the labyrinthine vasculature. Understanding the respective 
role of autotaxin, Foxf1 and Tie2 in Hoxa13-/- labyrinth phenotype will require their 
conditional inactivation in Hoxa13-expressing cells. 
  
Although endothelial cells in the allantois do not express Hoxa13, analysis of the 
Hoxa13Cre/HoxAflox mutant shows that the slight delay inherent to the Cre-mediated gene 
deletion is sufficient to ensure proper expansion of the fetal vasculature in the labyrinth and 
thus, embryonic survival. This result suggests that Hoxa13 expression in the allantois is 
critical for subsequent development of the labyrinthine vasculature and is consistent with 
our in situ hybridization analysis showing that Hoxa13 as well as Hoxa10 and Hoxa11 
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expression is only detectable until e9. The discrepancy between our expression data and 
that reported previously by Shaut et al. (2008) likely results from the difference in the 
experimental approach chosen. Indeed, while we used whole-mount in situ to visualize 
Hoxa13 transcripts, Shaut et al. analyzed the fluorescence of the Hoxa13-GFP allele, i.e. 
the protein produced by this targeted allele. Nevertheless, proper labyrinth development in 
our conditional mutant, together with the genetic fate map of Hoxa13-expressing cells and 
in situ data, indicates that the primary function of Hoxa13 in the extra-embryonic 
compartment relies on its early expression in the allantois. As a consequence, 
implementation of the mechanism underlying Hoxa13 transcriptional activation in the 
allantois was likely critical for species requiring the function of a chorio-allantoic placenta 
to ensure embryonic survival. Our analysis also shows that Hoxa10 and Hoxa11 are co-
expressed with Hoxa13 in the allantois indicating that extra-embryonic recruitment was not 
restricted to Hoxa13. Analysis of several targeted rearrangements within and outside the 
HoxA cluster reveals that the mechanism underlying expression of these 5’Hoxa genes in 
the allantois involves at least two transcriptional enhancers, one of which is located within 
the 50 kb Hoxa13-Evx1 intergenic region. Surprisingly, subdivision of this intergenic 
region into smaller DNA fragments failed to recapitulate reporter gene expression in the 
allantois. Similar result was obtained for the tail bud/trunk expression. In contrast, three of 
these overlapping transgenes were able to drive reporter expression in developing limbs, 
which recapitulates the limb enhancer activity of the entire 50 kb region (IR50 transgene), 
thereby establishing that allantois and tail bud expression rely on cis-regulatory sequences 
  
 
81 
distinct from those driving expression in limbs. Loss of reporter expression in the allantois 
and tail bud upon fractioning of the Hoxa13-Evx1 intergenic region raises the possibility 
that both expression patterns could rely on the same regulatory sequences. In this view, the 
extra-embryonic recruitment of 5’Hoxa genes could be the consequence of the functional 
co-option of the tail bud enhancer in the allantois, both tissues being epiblast derivatives. 
However, in contrast to the IR50 transgene, 5’Hoxa genes are expressed in the allantois but 
not in the tail bud, at least up to e8.5. Thus, if expression of the IR50 transgene is driven by 
the same regulatory sequences in allantois and tail bud, absence of 5’Hoxa expression in 
the tail bud implies the existence of a repression mechanism preventing activation of the 
5’Hoxa genes in this tissue, consistent with the recent finding that precocious expression of 
5’Hox genes in the tail bud is detrimental for the posterior elongation of mice embryos 
(Young et al., 2009). Nonetheless, the fact that allantois expression could not be triggered 
using fragments of the Hoxa13-Evx1 intergenic region suggests that integrity of the latter 
50kb region is required to drive reporter expression in the allantois. It is widely accepted 
that long distance enhancer-promoter interaction involves chromatin looping. In this view, 
it is possible that both allantois and tail bud enhancers located in the Hoxa13-Evx1 
intergenic region require a defined three-dimensional chromatin organization to establish 
proper contacts with their target promoters. As a consequence, fractioning of the intergenic 
region would result in loss of proper chromatin organization while the distance between the 
enhancer and the minimal promoter of the reporter might be too large to ensure efficient 
transcriptional activation without chromatin looping. Consistent with this hypothesis, 
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analysis of Hoxd genes’ regulation in developing limbs revealed that the underlying control 
is extremely complex and cannot be easily assessed through the analysis of simple reporter 
transgenes (Tschopp and Duboule, 2011). 
 
Although, it remains to be established whether the recruitment of 5’Hoxa function 
in the allantois was elicited by the co-option of tail bud enhancer(s) or the implementation 
of evolutionary novel cis-regulatory sequences, Hoxa13-/- and HoxAdel/del placental 
phenotypes suggest that 5’Hoxa expression in the allantois is vital for the survival of mouse 
embryos and most probably for other placental species. Expression analysis in the allantois 
of chick embryos, which are non-placental amniotes, suggests that 5’Hoxa extra-embryonic 
recruitment likely occurred in amniotes, prior to the emergence of placental animals. It is 
thus likely that recruitment of 5’Hoxa genes in the allantois has subsequently played a key 
role in the implementation of the developmental strategy that characterizes placental 
species. It will be of particular interest to investigate whether the regulatory mechanism 
controlling 5’Hoxa expression in the allantois is conserved between placental and non-
placental amniotes or whether it has evolved concomitantly with the emergence of placental 
species. 
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2.6 Materials and Methods. 
2.6.1 Mouse strains.  
HoxAflox, Hoxa13null, Rosa26R, mT/mG, mox2Cre and CMV:Cre lines were 
previously described (Dupe et al., 1997; Fromental-Ramain et al., 1996b; Kmita et al., 
2005; Muzumdar et al., 2007; Soriano, 1999; Tallquist and Soriano, 2000). The HoxAdel 
line was generated by crossing HoxAflox mice with CMV:Cre partners. The TAMERE 
approach (Herault et al., 1998) was used to generate HoxAdelneo and del(5’) mutants 
(Kmita and Duboule, unpublished). HoxAdelneo was obtained from meiotic recombination 
of the HoxAflox allele and del(5’) from meiotic recombination between the Evx1flox 
(Goldman and Martin, unpublished) and HoxAflox alleles. In the Hoxa13Cre allele, Hoxa13 
first exon is replaced with the Cre:IRES:Venus cassette (Scotti and Kmita, in preparation). 
The IR50 transgene was generated using the recombineering technique (Copeland et al., 
2001). a-l transgenes carry the chicken βglobin minimal promoter and a LacZΔCpG NLS 
reporter. H19 insulators are located at both extremities of the transgenes. All transgenic 
embryos were generated by pronuclear injection. 
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2.6.2 In Situ Hybridization, Immunohystochemistry and X-gal 
staining. 
Whole mount in situ hybridizations were carried out using standard procedures 
(Kondo et al., 1998b; Nieto et al., 1996). Chicken probes are as previously described 
(Burke et al., 1995). Mouse Hoxa1 and Hoxa13 probes are described in (Dupe et al., 1997) 
and (Warot et al., 1997). Probe templates for Hoxa2, Hoxa3, Hoxa4, Hoxa5, Hoxa7, 
Hoxa9, Hoxa10 and Hoxa11 were provided by, respectively, J. Deschamps, C. Fromental-
Ramain et B. Tarchini. The hygromycine probe was generated using the 600bp EcoRI-
HincII coding sequence.  
 
Immunohistochemistry was carried out on 10-12 mm cryosections according to 
standard procedures or on whole-mount specimens as previously described (Gregoire and 
Kmita, 2008). Antibodies against CD31 (BD Bioscences 1: 100) and beta-galactosidase 
(Cappel 1:1000) were used. The mT/mG Cre reporter allele expresses GFP at the cell 
membrane and thus direct GFP fluorescence was used for co-localization with CD31, 
which is also expressed at the cell membrane. X-gal staining on embryos and placentas was 
carried out as described in (Downs and Harmann, 1997) and according to (Zakany et al., 
1988) for older specimens. Immunostaining on sections were imaged using ZEISS LSM710 
confocal microscope. For all analyses of placenta sections, we used only sections that 
encompassed the junction with the allantois/umbilical cord to ensure accurate comparison 
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of the various placenta specimens. For each genotype and stage, analyses were performed 
on a minimum of three placentas. 
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2.8 Legends to figures.  
Figure 2.1 Deletion of the HoxA cluster leads to impaired 
vasculature in the placental labyrinth.  
Histology of wild type (A) and mutant (B) placentas at e10.5 as revealed by 
hematoxylin and eosin staining on paraffin sections. At high magnification (C-D), the 
mutant labyrinth appears more compact, likely as a consequence of reduced fetal 
vasculature (D). (E-F) Whole mount CD31 immunostaining labelling the vascular 
endothelium of wild type (E) and HoxAdel/del (F) hemi-placentas at e10.5. (G, H) 
Magnifications of boxed areas in (E, F). In the wild type placenta, the vasculature expands 
into the entire labyrinth (E, G). In the mutant (F, H) large labyrinth regions are deprived of 
vasculature and characterized by absence of brown staining (H, black dotted lines delimit 
vasculature-deprived regions within the labyrinth). Immunohistochemical analysis of CD31 
expression on cryosections of wild type (I) and mutant (J) placentas at e10.5 (n=11). 
Yellow arrows point to the large regions deprived of endothelial cells in the mutant 
labyrinth (J). In all panels white dotted lines mark the boundary between the labyrinthine 
region and the decidua. dec, decidua; lab, labyrinth. Scale bars 200 µm. 
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Figure 2.2 Hoxa10, Hoxa11 and Hoxa13 are the only members of 
the HoxA cluster expressed in the allantois.  
Wild type expression patterns of Hoxa genes as revealed by whole mount in situ 
hybridization on e7.5 (top), e8.5 (middle) and e9.5 (bottom) conceptuses. At e7.5 and e8.5, 
only the most 5’ located genes (Hoxa10, Hoxa11 and Hoxa13) are expressed in the 
allantois (black arrows). Note that these genes are expressed prior genes located at more 3’ 
positions. At e8.5, all Hoxa genes are transcriptionally activated, but none of the group 1 to 
9 Hoxa genes are expressed in the allantois (white arrows). In contrast, 5’Hoxa expression 
in the allantois is barely, if at all, detectable in e9.5 allantois and there is no evidence for 
Hoxa expression in the labyrinth (bottom panel, dotted circles). 
 
Figure 2.3: Initial expression of Hoxa13 does not occur in 
endothelial cells of the allantoic vasculature.  
(B) Whole mount X-gal staining Hoxa13Cre/+;Rosa26R/+ conceptus  at e8.5 
reveals the fate of cells that have expressed Hoxa13 at e7.5 (A). Note the significant 
proportion of Hoxa13lin+ cells at the chorio-allantoic interface. (C-E) Immunostaining on 
allantois cryosections showing that most of Hoxa13lin+ cells  (green) do not express the 
endothelial cell marker CD31 (red) at e8.5. The mT/mG Cre reporter allele expresses GFP 
at the cell membrane and thus was used for co-localization with CD31, which is also 
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expressed at the cell membrane. Nuclei are labeled with DAPI (gray staining). Dotted lines 
in panel B-E highlight the limit between the allantois and chorionic plate.  all, allantois. 
cho, chorionic plate. E, embryo. Scale bars 100 µm.   
 
Figure 2.4: Hoxa13lin+ cells become progressively endothelial 
only in the labyrinth.  
(A) beta-galactosidase activity reveals that Hoxa13lin+ cells is restricted to the 
allantois and placental labyrinth. (B-D) Co-immunostaining for Hoxa13lin+ cells and 
endothelial cells at e9.5. (E) Whole mount X-gal staining on e16.5 placenta. 
Immunostaining showing both Hoxa13lin+ and endothelial cells in mature placental 
labyrinth (F-H) and umbilical cord (J-L) at e16.5. mT/mG  Cre-reporter was used to mark 
Hoxa13lin+ cells such that both the reporter protein and CD31 signals are targeted to the 
cell membrane and allows unambiguous detection of protein co-localization (D, white 
arrows). Nuclei are labeled with DAPI (gray staining). (I) Percentage of Hoxa13lin+ signal 
co-localized with CD31+ signal at distinct stages of labyrinthine development. Scale bars 
30 µm. 
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Figure 2.5: Delay in the induction of Hoxa13 inactivation is 
sufficient to ensure proper development of the labyrinth and 
survival of the embryo. 
(A-C) CD31 immunostaining on placenta cryosections at e14.5. 
Hoxa13Cre/HoxAflox labyrinthine vasculature (B) is comparable to wild type (A). (D-E) 
Forelimbs and hindlimbs of control (left, HoxAflox/+) and mutant (right, 
Hoxa13Cre/HoxAflox) mice at 6 months of age. Mutant limbs show a fully penetrant 
phenotype associated with the loss of Hoxa13, such as lack of digit 1 (white asterisk), 
shortening and malformation of the other digits in the forelimb and fusion of digit 2, 3 and 
4 in the hindlimb (black arrows). Scale bars 200 µm.  
 
Figure 2.6: Expression of 5’Hoxa genes in chick allantois, and 
evidence for a shared allantois enhancer in mice. 
(A) Whole mount in situ hybridization on chick embryos at stage HH18. Hoxa13 
and Hoxa11 are expressed in the allantois (middle and right panels) but not Hoxa9 (left 
panel), illustrating that 5’Hoxa expression in the allantois is not restricted to placental 
species. Schematic representation of the wild-type HoxA cluster (B) and alleles carrying 
rearrangements or deletions within the HoxA cluster (C, D and E). For each allele, 
  
 
90 
expression pattern for 5’ Hoxa genes, Evx1 or PGK transgenes is shown. (B), Wild type 
expression of Hoxa13. (C), The PGK promoter is activated in the allantois when inserted at 
the 5’ end of the HoxA cluster (HoxAflox allele). (D), The PGK transgene remains 
expressed in the allantois even in absence of the entire HoxA cluster (HoxAdelneo+). (E), 
Evx1 expression remains excluded from the allantois even when the HoxA cluster is deleted 
(HoxADel allele). Wild-type expression of Evx1 (black box). (F), The IR50 transgene, 
containing the 50kb Hoxa13-Evx1 intergenic region linked to the minimal promoter and 
lacZ reporter, is expressed in the allantois.  
 
Figure 2.7: Deletion of the Hoxa13-Evx1 intergenic region does 
not prevent Hoxa10, Hoxa11 and Hoxa13 expression in the 
allantois.  
Whole mount in situ hybridization for 5’Hoxa genes or PGK transgenes in 
HoxAflox/flox (top) and Del(5’)/Del(5’) embryos (bottom) at e8.5. These rearrangements in 
the vicinity of the HoxA cluster do not prevent 5’ Hoxa expression in the allantois nor that 
of the PGK-transgene. Note that deletion of the 50kb Hoxa13-Evx1 intergenic region 
(Del5’) does not interfere with 5’Hoxa expression in the tail bud. Arrows point to the 
allantois.
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Figure 2.2 Hoxa10, Hoxa11 and Hoxa13 are the only members of the
HoxA cluster expressed in the allantois.
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Figure 2.6 Expression of 5’Hoxa genes in chick allantois, and evidence 
for a shared allantois enhancer in mice. 
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2.9 Legends to supplementary figures.  
 
Figure S 2.1 Expression of Hoxa10 and Hoxa11 is detected at 
early stages in the allantois, but is not maintained in the 
allantois-derived labyrinthine vasculature. 
Wild type expression patterns of Hoxa10 and Hoxa11 at different stages of 
development as revealed by whole mount in situ hybridization. At e8.5 (A,B), 5’Hoxa 
genes expression is only detected in the allantois and is excluded from the chorionic plate 
(arrows). At e9.5 (C,D) , e10.5 (E,F)  and e12.5 (G,H) 5’Hoxa genes are detected in the 
embryo proper and in the decidua, but not in the labyrinth. F, insert, whole mount in situ 
hybridization for Hand1 showing expression in the labyrinth. The Hand1 RNA probe was 
provided by A.Galli. E, embryo; lab, labyrinth; dec, decidua. 
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Figure S 2.2 Inactivation of Hoxa genes does not interfere with 
the formation of the primary vascular plexus within the 
allantois. 
Whole mount CD31 immunostaining on control (A,B) and HoxAdel/del (C,D) 
allantois at 2 somite- (A,C) and 14 somite- (B,D) stage reveals the spatial distribution of 
endothelial cells. All allantois were imaged and photographed using a ZEISS LSM710 
confocal microscope.  prox, proximal; dist, distal; E, embryo. Scale bar 100 μm. 
 
Figure S 2.3 The fetal vasculature of the mature labyrinth is 
formed of Hoxa13lin+ and Hoxa13lin- endothelial cells. 
(A,B) Hoxa13 lineage in distal forelimb buds of e11.5 Hoxa13Cre/+; mT/mG 
embryos illustrates that the Hoxa13Cre is an efficient tool to trace the fate of Hoxa13 
expressing cells. Hoxa13lin+ cells express the green fluorescent protein (mG) while cells in 
which there is no Cre-mediated recombination express Tomato (mT-red staining). The only 
cells expressing mT are ectodermal cells and blood cells, which do not express Hoxa13. (C-
E) CD31 immunostaining on cryosections of e16.5 Hoxa13Cre/+; mT/mG labyrinth. 
Arrows point to capillaries formed of both Hoxa13lin+ and Hoxa13lin- cells. Few 
capillaries are only formed of Hoxa13lin- cells (compare C and D). Scale bar 35 μm. 
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Figure S 2.4: Hoxa13 function is dispensable for endothelial cell 
differentiation. 
Fate mapping of Hoxa13-expressing cells in e14.5 control (A-C) and Hoxa13 null 
(D-F) placental labyrinths. In absence of Hoxa13 function, there is a significant reduction 
of the Hoxa13lin+ cell population (compare A and D) that coincides with the reduced 
endothelial cell population (B,E). Even in absence of Hoxa13 function, most of Hoxa13lin+ 
cells are endothelial (CD31+) cells (C,F). Scale bars 200 µm. 
 
Figure S 2.5: The yolk sac from HoxAdel/del mutant is 
indistinguishable from wild-type yolk sac. 
Wild type (A,B) and HoxAdel/del (C,D) samples at e11 photographed immediately 
after dissection. HoxAdel/del embryos have properly vascularized yolk sacs and are 
indistinguishable from yolk sacs of wild type littermates. Accordingly, X-gal staining on 
Hoxa13Cre/+; Rosa26R specimens shows no Hoxa13lin+ cells in the yolk sac (E). 
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Figure S 2.6: Loss of allantois expression upon subdivision of the 
Hoxa13-Evx1 intergenic region. 
Schematic representation of sequence conservation of the Hoxa13-Evx1 intergenic 
region between mouse, human and chick (VISTA browser alignment). Top panel: IR50 
transgenic embryo at e12.5 and magnification of the forelimb. Bottom panel: representation 
of the IR subclones (a-l). Subdivision of the Hoxa13-Evx1 intergenic region has been 
designed to maintain the integrity of conserved DNA sequences and each two neighboring 
DNA fragments are overlapping at their common extremity. c, g and f transgenes express 
the reporter gene in the forelimb at e12.5 (see arrows and magnification of the forelimbs). 
Transgene “l” is not expressed in the forelimb, but in the central nervous system at e12.5 
(arrowheads). Right panel, magnification of the staining in the neural tube (dorsal view). 
The latter pattern, absent in IR50 transgenic embryos, is reminiscent of Evx1 expression in 
the neural tube. Since, the reporter in the IR50 transgene is located at the opposite end 
compared to region “l”, absence of neural tube expression in IR50 transgenic embryos 
suggests that this expression pattern is under the control of a short-range cis-regulatory 
element or restricted to Evx1 as a consequence of an insulator element.  
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Figure S 2.1 Expression of Hoxa10 and Hoxa11 is detected at early
stages in the allantois, but is not maintained in the allantois-derived 
labyrinthine vasculature. 
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Figure S 2.3 The fetal vasculature of the mature labyrinth is formed of Hoxa13lin+ 
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Tg	  name	   Start	  position	   End	  position	   E8.5	  Tg/total	   E8.5	  Expressing/Tg	  (allantois)	   E8.5	  Expressing/Tg	  (tail	  bud)	   E12.5	  Tg/total	   E12.5	  Expressing/Tg	  (limb)	   E12.5	  Expressing/Tg	  (tail)	  a	   6:52214326	   6:52215187	   8/43	   0/8	   0/8	   12/45	   0/12	   0/12	  b	   6:52215554	   6:52216314	   7/25	   0/7	   0/7	   10/36	   0/10	   0/10	  d	   6:52216243	   6:52220703	   9/45	   0/9	   0/9	   4/33	   0/4	   0/4	  e	   6:52220683	   6:52221080	   7/68	   0/7	   0/7	   13/52	   0/13	   0/13	  g	   6:52226204	   6:52226809	   13/42	   0/13	   0/13	   10/44	   7/10	  	   0/10	  f	   6:52225971	   6:52231612	   7/23	   0/7	   0/7	   9/34	   4/9	  	   0/9	  c	   6:52215337	   6:52227090	   7/45	   0/7	   0/7	   4/54	   4/4	  	   0/4	  h	   6:52231584	   6:52240112	   5/29	   0/5	   0/5	   6/50	   0/50	   0/50	  i	   6:52240064	   6:52243437	   15/53	   0/15	   0/15	   7/31	   0/7	   0/7	  j	   6:52241134	   6:52251078	   8/37	   0/8	   0/8	   10/47	   0/10	   0/10	  k	   6:52250154	   6:52258385	   6/38	   0/6	   0/6	   3/38	   0/3	   0/3	  l	   6:52258283	   6:52264475	   9/68	   0/9	   0/9	   4/72	  	   0/4	   0/4	  
Table S 2.1 Transgenic analysis of the intergenic region between Hoxa13 and Evx1 
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Hoxa13 expressing cells and their descendants to the 
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3.2 Abstract: 
Gene expression pattern in the developing embryo provides important information 
on tissue(s)/organ(s) where the gene is expected to be functional. Yet, such correlation is 
less obvious when expression occurring prior cell fate specification. In addition, it should 
be taken into account that the phenotypic outcome of a gene function can be sometimes 
detectable only after the gene is silenced. To circumvent this issue, genetic fate mapping 
using the loxP-Cre recombination system has proven invaluable. Here, we use genetic fate 
mapping to establish the tissues and organs originating from Hoxa13-expressing cells. Our 
results show that cells expressing Hoxa13 in developing limb buds contribute to all bones 
of the forelimb autopod and validate Hoxa13 as a distal limb marker as far as the skeleton 
is concerned. The situation is different in limb muscles, where in addition to autopod 
muscles, Hoxa13-expressing cells give rise to almost all muscular masses of the zeugopod 
and few masses of the stylopod.  Together with previous expression data, our results 
demonstrate that the contribution of Hoxa13-expressing cells along the limb proximo-distal 
axis is significantly different depending on the limb tissue. Importantly, the contribution of 
these cells to only a subset of limb muscles is, to our knowledge, the first example of a 
genetic marker specific for a defined subgroup of limb muscles. This result raises the 
possibility of Hoxa13 being involved in establishing specific features of these muscles. 
Finally, the Hoxa13Cre line used in this study should be a valuable tool to study musculo-
skeletal development and diseases. 
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3.3 Introduction: 
The Hox family of transcription factors plays a key role in the establishment of the 
body architecture (Iimura and Pourquie, 2007; Kmita and Duboule, 2003; Young and 
Deschamps, 2009). This function is conserved throughout the animal kingdom and relies on 
the differential combination of Hox proteins along the anterior-posterior axis of the 
developing embryo. Besides their ancestral role in patterning of the primary body axis, Hox 
genes have been repetitively recruited to achieve novel functions during evolution, such as 
the morphogenesis of vertebrate limbs (Zakany and Duboule, 2007). In mammals, there are 
39 Hox genes organized in four clusters, referred to as HoxA, B, C and D. Each Hox cluster 
contains a series of 9 to 11 contiguous genes transcribed from the same DNA strand, thus 
defining a 5’ to 3’ polarity to the cluster. Due to the common origin of these clusters, genes 
located at the same relative position on different clusters (referred to as paralogous genes) 
share more sequence similarities than genes located on the same cluster (Krumlauf, 1994). 
Genes belonging to group 1 are located on the 3’-end of the clusters and are the first to be 
expressed. Moreover, group 1 genes are expressed in the anterior-most domains of the 
embryo compared to genes located in the 5’-end of the clusters (Kmita and Duboule, 2003).  
Hoxa13 is the most 5’ member of the HoxA cluster. In the mouse, its expression is 
first detected at embryonic day (e) 7.5 in the allantois, an extra-embryonic epiblast 
derivative located in the exocoelom (Scotti and Kmita, 2012). However, this expression is 
transient, and by e9.5, Hoxa13 expression is restricted to embryonic structures (Scotti and 
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Kmita, 2012). At e9.5, Hoxa13 mRNA is observed in the tail bud, and by e10 in the distal 
posterior region of the developing forelimb bud mesenchyme (Haack and Gruss, 1993). At 
e11, a similar expression pattern is detected in the hindlimb. Between e11 and e13, Hoxa13 
expression domain in the limb encompasses the mesenchyme of the entire presumptive 
autopod (hand/foot) and becomes restricted to peridigital tissue and interarticular 
condensations of digits by e14 (Stadler et al., 2001). Faint Hoxa13 expression is also 
detected in the zeugopod and stylopod (forearm and arm) of the developing limb, in a 
domain corresponding to the developing musculature (Yamamoto and Kuroiwa, 2003).  
Moreover, Hoxa13 mRNA is observed in the genital bud starting from e11.5, and at e14 in 
the urogenital system and gastrointestinal tract (Warot et al., 1997).  
In mouse, loss of function of Hoxa13 results in embryonic lethality at mid-gestation 
due to impaired development of the vasculature within the placental labyrinth (Fromental-
Ramain et al., 1996b; Shaut et al., 2008). Mutant embryos display a severely defective 
urogenital system, characterized by hypoplasia of the urogenital sinus, absence of bladder 
and abnormal localization of ureters extremities (Warot et al., 1997). In the limb, 
inactivation of Hoxa13 causes defects in the autopod. These include lack of digit 1, 
shortening and malformation of the other digits, fusion of the interdigital tissue and absence 
of pre-cartilaginous condensation for carpal and tarsal elements (Fromental-Ramain et al., 
1996b). The autopod phenotype of Hoxa13-/- mutants is, at least in part, due to cell 
adhesion defects in cartilage condensations and reduced apoptosis in the interdigital tissue 
(Knosp et al., 2004; Salsi and Zappavigna, 2006; Stadler et al., 2001). However, the simple 
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Hoxa13 inactivation provides only partial information on Hoxa13 functional properties. For 
instance, the simultaneous inactivation of Hoxa13 and Hoxd13 often results in a 
significantly more severe phenotype than the addition of individual gene loss-of-function 
phenotypes as a consequence of functional redundancy and synergism (Fromental-Ramain 
et al., 1996b; Warot et al., 1997). In addition, Hoxa13-/- mutants have defects in 
tissues/organs where Hoxa13 expression is not detected but instead is associated with 
expression in progenitor cells, as reported for Hoxa13 function in the development of the 
placental labyrinth (Scotti and Kmita, 2012).  
To establish the tissues and organs originating from Hoxa13-expressing cells, we 
generated a novel Hoxa13 allele to genetically mark Hoxa13-expressing cells and their 
descendants. The resulting fate-map allowed us to identify all organs and tissues derived 
from Hoxa13-expressing cells. In particular, our analysis demonstrates that Hoxa13 
expressing cells contribute exclusively to skeletal elements of the autopod, thereby 
confirming that Hoxa13 can be used as a specific marker for distal skeletal elements. Our 
fate-map also shows that autopod, zeugopod and stylopod muscles stem in part from 
Hoxa13-expressing cells. Thus, while this study demonstrates that Hoxa13 can be used as a 
distal marker as far as the skeleton is concerned, starting at e12 its expression cannot be 
used as a marker specific for cells committed to distal fate. Importantly, our analysis shows 
that the contribution of Hoxa13-expressing cells and their descendants (Hoxa13lin+) to the 
limb musculature is restricted to muscle fibers of a specific subset of muscles. Moreover, 
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the proportion of Hoxa13lin+ cells varies between these muscles, as well as between fibers 
of a given muscles suggesting a molecular heterogeneity of the myocytes.  
3.4 Results:  
3.4.1 Generation and validation of the Hoxa13Cre mice. 
To map the fate of Hoxa13-expressing cells in the developing embryo, we targeted a 
Cre:Ires:Venus cassette into the Hoxa13 start codon via homologous recombination in ES 
cells (Fig. 3.1A). After neomycin selection, recombinant clones were screened by Southern 
blot analysis. Successful targeting was confirmed by a restriction fragment length 
polymorphism detectable with the external probe, and absence of additional random 
insertion was verified using the internal probe (Fig. 3.1B, C). Two targeted clones were 
injected in mouse blastocysts to generate chimeras. Following germline transmission of the 
Hoxa13Creneo+ allele, the neomycin selection cassette was eliminated in vivo by crossing 
Hoxa13Creneo+/+ mice with FLPeR partners (Farley et al., 2000) (Fig. 3.1D). Hoxa13Creneo-
/+ animals (named Hoxa13Cre/+ hereafter) are fully viable and fertile but Hoxa13Cre 
homozygous mutants die embryonically of placental defects (Scotti and Kmita, 2012), 
which is consistent with other Hoxa13-null mutant previously reported (Shaut et al., 2008) 
(Stadler et al., 2001) (Fromental-Ramain et al., 1996b).  
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Venus reporter expression was never detected either by direct fluorescence analysis 
or using immunostaining on sections (not shown). Therefore, in our studies, we were not 
able to use the Venus reporter to monitor real-time Hoxa13 expression.  
To verify that the Cre cassette works properly in our Hoxa13Cre allele, we crossed 
Hoxa13Cre/+ males with homozygous females from the Cre reporter strain Rosa26R 
(Soriano, 1999). X-gal staining performed on e10.5 Hoxa13Cre/+; Rosa26R/+ embryos 
showed that Cre reporter expression is comparable to Hoxa13 expression pattern at this 
early stage, indicating that our Hoxa13Cre allele is functional and can be used to establish 
the fate map of Hoxa13-expressing cells (Fig. 3.2D, E).  
 
3.4.2 Hoxa13 fate-mapping analysis in the developing embryo. 
To explore the fate of Hoxa13 expressing cells in the developing embryo, we 
crossed Hoxa13Cre/+ males with the Rosa26R Cre reporter strain and compared the 
reporter activity with Hoxa13 mRNA distribution. In Hoxa13Cre/+; Rosa26R/+ mutants, a 
transcriptional stop cassette is excised in presence of the Cre recombinase, irreversibly 
activating the β-gal reporter expression in all Hoxa13 expressing cells and their 
descendants, hereafter referred to as Hoxa13lin+ cells. As previously reported, Hoxa13 
expression in the developing forelimb starts at e10.0 in the distal bud (Fig. 3.2A, arrow). 
However, whole mount X-gal staining of Hoxa13Cre/+; Rosa26R/+ embryos showed that 
the Cre reporter activity is only detectable in the forelimb bud starting from e10.75 (Fig. 
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3.2B, E), consistent with the delay between Cre transcriptional activation and synthesis of 
the β-gal reporter protein (Scotti and Kmita, 2012). Subsequently, we found that 
mesenchymal cells within the entire presumptive autopod region are Hoxa13lin+ (Fig. 
3.2H, K, N), a fate map reminiscent of Hoxa13 expression profile (Fig. 3.2G, J, M). From 
e11.5 onwards, Hoxa13lin+ cells are no longer restricted to the presumptive autopod and 
are found in more proximal regions of the developing limb.  In contrast, Hoxa13 expression 
in the proximal limb domain is barely detectable by whole-mount in situ hybridization. 
Hoxa13 is also expressed in the developing hindlimb, with a pattern similar to the 
one observed in the forelimb (Fig. 3.2D, G, J, M). In contrast, Hoxa13lin+ cells are found 
throughout the hindlimb from early bud stage onwards, though with a primary contribution 
to the autopod domain (Fig. 3.2B, E). Such difference between Hoxa13 expression in 
hindlimbs and the distribution of Hoxa13lin+ cells suggests that early and proximal Cre 
reporter activity is the consequence of Hoxa13 expression in the lateral plate mesoderm, 
from which limb mesenchymal cells originate.    
During development, Hoxa13 is initially activated in the extra-embryonic 
compartment marking cells of the allantois, the precursor of the umbilical cord (Scotti and 
Kmita, 2012). By e9.0, Hoxa13 is expressed in the tail bud (Fig. 3.2A, D arrowhead) and 
accordingly, X-gal staining is observed in the tail bud of Hoxa13Cre/+; Rosa26R/+ 
embryos starting from e10.0 (Fig. 3.2B, C). Subsequently, X-gal positive cells are located 
in the posterior mesoderm and neural tube, the X-gal staining being more posteriorly 
restricted in the mesoderm (Fig. 3.2F, I, L). Hoxa13lin+ cells are also detected in the 
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umbilical cord and developing genitals of Hoxa13Cre/+; Rosa26R/+ embryos (Fig. 3.2C, 
F, L, O), consistent with Hoxa13 expression in these structures (Warot et al., 1997). 
Hoxa13 expression has been previously reported in the distal part of the urogenital and 
gastrointestinal tracts (Warot et al., 1997). Accordingly, we found Hoxa13lin+ cells in the 
developing ureters, bladder, caudal portions of the Müllerian and Wolffian ducts (Fig. 
3.2Q). In addition, we observed a strong contribution of Hoxa13lin+ cells to the rectum and 
colon, as well as a modest contribution to the developing cecum (Fig. 3.2R).  
3.4.3 Hoxa13-expressing cells and their descendants mark a 
subpopulation of myogenic progenitors in the developing 
forelimb pre-muscular masses. 
Although Hoxa13 is predominantly expressed in the presumptive autopod region, 
Hoxa13 expressing cells have been identified in limb myogenic precursors of avian 
embryos and limb muscles of avian and mice limbs (Dolle et al., 1989; Haack and Gruss, 
1993; Perez et al., 2010; Yamamoto et al., 1998; Yamamoto and Kuroiwa, 2003). By e12.0, 
Hoxa13lin+ cells are found in the proximal forelimb, with a spatial distribution that looks 
similar to the localization of developing muscles. To better define and characterize the fate 
of Hoxa13-expressing cells in the proximal region of the developing forelimb, we 
performed X-gal staining on Hoxa13Cre/+; Rosa26R/+ forelimbs starting from early bud 
stage. To achieve a more precise staging of our samples, somites of the embryos were 
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counted. We found that, starting from 45-somite stage, few scattered X-gal positive cells 
are present within the proximal region of the forelimb (Fig. 3.3D arrow) and by 53-somite 
stage there is a distinct “patch” of Hoxa13lin+ cells in the presumptive zeugopod-stylopod 
region (Fig. 3.3F arrow).  
Limb muscles derive from Pax3-expressing myogenic progenitors that delaminate 
from the hypaxial dermomyotome and migrate in the limb bud (Chevallier et al., 1977) 
(Daston et al., 1996; Williams and Ordahl, 1994). Based on whole-mount X-gal staining, 
proximal Hoxa13lin+ cells are either overlapping with myogenic precursors or located in 
their vicinity. To confirm the identity of Hoxa13lin+ cells, we performed double 
immunostaining for the Cre-reporter protein and Pax3 on transverse cryosections. The Pax3 
antibody requires antigen retrieval treatment to recognize the protein epitope, however, the 
anti-βgal antibody, used to detect X-gal positive cells, does not work properly under these 
experimental conditions. Thus, for our analysis on sections, we used samples derived from 
the mT/mG Cre reporter strain that produces a green fluorescent protein (GFP) after Cre-
mediated recombination (Muzumdar et al., 2007). In Hoxa13Cre/+; mT/mG embryos a 
green fluorescent membrane-targeted protein (mG) is expressed in cells where Cre-
mediated recombination has occurred, while a red fluorescent membrane-targeted protein 
(mT) is expressed in the other cells. At all stages analyzed, Hoxa13Cre mediated 
recombination was detected in the limb mesenchymal cells and not in the limb ectoderm, 
(Fig. 3.4). At 47-somite stage, Pax3+ cells form two distinct ventral and dorsal pre-
muscular masses in forelimb buds (red nuclear signal in Fig. 3.4B). These masses extend 
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distally into the limb (Fig. 3.4C) and few scattered GFP+/Pax3+ double positive cells are 
found in the central and distal regions of the ventral and dorsal pre-muscular masses (Fig. 
3.4C dotted box). By 53-somite stage, the GPF+/Pax3+ double positive cell population has 
drastically increased and is located within the entire pre-muscular masses (Fig. 3.4F and 
dotted boxes).  
 
3.4.4 Hoxa13lin+ cells form muscular fibers of a subset of limb 
muscles. 
Pax3-expressing cells, which form the pre-muscular masses of the limb, activate a 
myogenic transcriptional program triggering differentiation into myoblasts in a proximal-
to-distal manner (reviewed in (Christ and Brand-Saberi, 2002)). Myoblasts subsequently 
fuse into multinucleate myotubes and assemble to generate muscle fibers (reviewed in 
(Francis-West et al., 2003)). To follow the fate of Pax3+/Hoxa13lin+ myogenic progenitors 
during forelimb muscular development, we performed whole mount X-gal staining on 
Hoxa13Cre/+; Rosa26R/+ specimens at successive stages (Fig. 3.5 A-E). By e12.5, 
additional domains of X-gal staining are observed in the presumptive zeugopod and the 
posterior domains appear more proximal than the anterior ones (Fig. 3.5A). Later on, 
Hoxa13lin+ cells are detected in almost all dorsal muscles of the zeugopod (Fig. 3.5 B-E). 
The developing stylopod musculature contains much less Hoxa13lin+ cells, which are 
restricted to part of the forming triceps (Fig. 3.5E). We next performed a more detailed 
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analysis by immunostaining on cryosections of Hoxa13Cre/+; mT/mG forelimbs. 
Hoxa13lin+ cells were visualized by direct detection of GFP fluorescence from the mT/mG 
Cre reporter allele, while muscles fibers were labeled by immunostaining for the Myosin 
Heavy Chain. Tendons were identified on the basis of their morphology and anatomical 
position. In the autopod of Hoxa13Cre/+; mT/mG forelimbs, we found that all muscles, 
tendons and ligaments are GFP positive (Fig. 3.6 and not shown).  
To follow the fate of Hoxa13 expressing cells and their descendant and highlight 
possible variations in the Hoxa13lin+ cells contribution at different stages of muscle 
development, we analyzed transverse sections of the zeugopod and stylopod at e14.5 and 
e18.5. At all stages analyzed, Hoxa13lin+ cells are only localized in the muscle fibers, and 
excluded from the connective compartment of the muscle, as well as from tendons and 
ligaments (Fig. 3.7A, C and Fig. 3.8A, C arrowhead and not shown).  At e14.5, Hoxa13lin+ 
cells are observed in all distal muscles of the zeugopod, but there are apparent differences 
in the level of GFP fluorescence between the various muscle masses (Fig. 3.7A-C). GFP 
fluorescence is also detected in muscular masses of the proximal zeugopod, but not all 
muscles were labeled (Fig. 3.7D-E). The most anterior muscle in the proximal-ventral part 
of the zeugopod (extensor carpi radialis longus #11 in Fig. 3.7D) is completely deprived of 
Hoxa13lin+ cells (Fig. 3.7D-F). In the e14.5 stylopod, Hoxa13lin+ cells contribute to the 
formation of the triceps (triceps brachii radialis and lateralis #19 and 18, Fig. 3.7G, L). No 
Hoxa13lin+ cells are detectable in the other stylopod muscles (Fig. 3.7I).  
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The distribution of Hoxa13lin+ cells in e18.5 zeugopod appears very similar to 
e14.5, with stronger GFP fluorescence in distal muscles and less GFP-positive fibers in 
more proximal masses (Fig. 3.8A-F). In the stylopod, Hoxa13lin+ cells are found 
exclusively in the triceps, with a predominant contribution to the radialis and lateralis and a 
minor contribution to the dorsal portion of the triceps longus (Fig. 3.8G-L). Interestingly, at 
all stages analyzed, fibers within the same muscle are also characterized by different GFP 
fluorescence intensity, and fibers with similar intensity are often clustered in the same 
region of the muscle (Fig. 3.8D, G #10, 14, 15, 12, 9). 
 
3.4.5 Hoxa13lin+ cells contribution to the limb skeleton is 
restricted to the autopod. 
To determine Hoxa13lin+ cells contribution to the limb skeletal elements we 
performed sagittal sections at the autopod/zeugopod junction of e18.5 specimens. We found 
that the entire skeleton of the autopod is composed of Hoxa13lin+ cells (Fig. 3.6A,G). 
Moreover, each bone element of the autopod is completely formed by Hoxa13lin+ cells, 
with the exception of the most proximal carpal elements (ulnare, radiale and intermedium), 
in which some lineage negative cells are found (Fig. 3.6D-F). In contrast, no Hoxa13lin+ 
cell was detected in the radius, and we could only differentiate few Hoxa13lin+ in the ulnar 
head, (Fig. 3.6D) suggesting that Hoxa13-expressing cells and their descendants establish a 
boundary between autopod and zeugopod bones (Fig. 3.6A). 
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3.5 Discussion.  
To define tissues and organs deriving from Hoxa13-expressing cells during 
development, we generated the Hoxa13Cre allele aimed at inducing permanent reporter 
expression in Hoxa13-expressing cells and their descendants (Hoxa13lin+) to establish the 
fate of Hoxa13-expressing cells. As anticipated from expression data, Hoxa13lin+ cells are 
detected in limbs, posterior trunk, urogenital system and gastrointestinal tract. Genetic fate 
mapping in the limb demonstrated that Hoxa13-expressing cells give rise to the entire 
autopod, except blood vessels and ectoderm, and to a specific subset of muscles in the 
zeugopod and stylopod. Moreover, our fate map uncovered the specific contribution of 
Hoxa13 expressing cells and their descendants to muscular fibers within limb muscles.  
Finally, we found that the contribution of Hoxa13-expressing cells and their descendents to 
the different limb muscles is not identical.  
3.5.1 Hoxa13 is a distal marker for the limb skeleton.  
Starting from e10.0, Hoxa13 is robustly expressed in the distal posterior region of 
the forelimb and by e11 its transcripts are located in the entire presumptive autopod (Dolle 
et al., 1989; Haack and Gruss, 1993). Based on these expression data, Hoxa13 has been 
used as a marker of the distal limb. Yet, to date there was no evidence that the fate of 
Hoxa13-expressing cells is restricted to distal elements of the limb skeleton. The fate map 
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of Hoxa13 expressing cells reported here demonstrates that skeletal progenitors expressing 
Hoxa13 and their descendants remain distally restricted. Moreover we found that, with the 
exception of the most proximal carpal elements, all skeletal elements of the autopod are 
exclusively formed by Hoxa13lin+ cells. Together, these data demonstrate that Hoxa13 is a 
bona fide marker of distal skeleton precursors.  
 
3.5.2 Hoxa13lin+ cells are part of the limb musculature. 
Limb muscles consist of two different components: somite-derived muscle tissue 
and connective tissue originating from the limb mesenchyme. The latter includes the 
different tendons and three layers of connective tissue that surround the muscular mass 
(Borg and Caulfield, 1980). Muscular tissue stems from myogenic progenitors, which are 
highly proliferating cells that differentiate into myoblasts. These myoblasts ultimately fuse 
together to generate the muscle fiber, a multinucleated cell forming the functional unit of 
the muscle (reviewed in e.g. (Biressi et al., 2007)). Expression analyses performed in avian 
and mouse embryos demonstrated that Hoxa13 expression in developing limbs is not 
restricted to the autopod domain, but is also detected in a subgroup of developing muscles 
of the zeugopod and the stylopod. In chick embryos, it has been reported that a 
subpopulation of limb myogenic progenitors of the dorsal and ventral pre-muscular masses 
starts expressing Hoxa13 once it has entered the limb bud territory (Yamamoto et al., 
1998). At later stages, both in mouse and chick, Hoxa13 mRNA is detected in a subset of 
  
 
126 
muscular masses of the zeugopod and stylopod (Yamamoto and Kuroiwa, 2003). However, 
the resolution of the in situ hybridization did not allow the exact localization of Hoxa13 
RNA within the muscle, and the contribution of Hoxa13 expressing cells to either the 
muscular or the connective compartment of the muscle was not clear. Consistent with 
previous studies, the fate map of Hoxa13-expressing cells shows that Hoxa13lin+ cells are 
present also outside the presumptive autopod domain. We detected these cells in mouse 
limb buds starting from 47-somite stage and identified them as Pax3+ myogenic 
progenitors within the limb pre-muscular masses. At later stages, co-immunostaining 
studies demonstrate that, in the zeugopod and stylopod, Hoxa13-expressing cells and their 
descendants contribute exclusively to muscle fibers and not to the associated connective 
tissue. Strikingly, GFP fluorescence intensity from the Cre reporter varies within individual 
muscles. Careful observation reveals distinct GFP fluorescence between fibers. Since these 
fibers stem from the fusion of myoblasts and are thus multinucleated, it is likely that 
differences in fluorescence intensity reflects the ratio of Hoxa13lin+/Hoxa13lin- myoblasts 
that contributed to the formation of individual fibers. In this view, the intensity of the GFP 
fluorescence of each muscular fiber would be directly proportional to the number of 
Hoxa13lin+ myobasts contributing to a given fiber. Alternatively, differences in 
fluorescence intensity could reflect a differential timing of Hoxa13 expression in the 
developing muscle. However, since the heterogeneity of the fluorescence does not change 
significantly over time, we favor the existence of a variable ratio of Hoxa13lin+/Hoxa13lin- 
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nuclei forming individual fibers of each muscle. It will be interesting to investigate whether 
such ratio has any impact on muscle function/identity. 
 
3.5.3 Hoxa13 function in the limb musculature.  
Although the molecular mechanisms that control skeletal patterning have been 
extensively studied, patterning and morphogenesis of limb muscles and other soft tissues, 
essential for a functional limb, are still poorly understood. Recent studies have reported that 
limb muscle patterning and differentiation are in part determined by extrinsic signals 
derived from the muscular connective tissue (Hasson et al., 2010; Kardon et al., 2003; 
Mathew et al., 2011). However, data obtained from non-limb myoblasts, suggest that 
intrinsic Hox-dependent cues could also play a role in muscle patterning (Alvares et al., 
2003). Hox genes are key regulators of patterning and specification in many different 
tissues, including the limb skeleton and motor neurons that innervate the limb (reviewed in 
(Dasen and Jessell, 2009; Zakany and Duboule, 2007)). In addition to Hoxa13, other Hox 
transcripts, such as Hoxa10 and Hoxa11, have been detected in both developing and adult 
limb muscles (Haack and Gruss, 1993; Yamamoto et al., 1998) (Benson et al., 1995; 
Houghton and Rosenthal, 1999). Yet, simple and compound Hox mutants have not been 
extensively analyzed for the presence of patterning or functional abnormalities of the limb 
musculature. While preliminary studies on Hoxa13-/- animals suggest patterning defects in 
limb muscles (Yamamoto and Kuroiwa, 2003), embryonic lethality associated with Hoxa13 
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inactivation has limited further analysis (Fromental-Ramain et al., 1996b). In addition, as 
the muscular and skeletal development is intimately linked and influences each other 
(Hasson, 2011), it is difficult to determine the specific role(s) of Hox genes in muscles 
formation and/or function using ubiquitous null alleles. Consistent with a potential role for 
Hoxa13 in the patterning of the limb musculature, our fate mapping analysis uncovered a 
differential contribution of Hoxa13lin+ cells to the different muscular masses within the 
limb. Yet, specific inactivation of Hoxa13 in myogenic precursors will be necessary to 
establish whether it plays a role in patterning the limb musculature. 
A functional limb requires the proper organization of muscles and bones and also 
correct muscle innervation (reviewed in (Bonanomi and Pfaff, 2010)). The identity of 
molecules implicated in nerve-muscle matching is still largely unknown. Previous 
experiments showed that in the limb, in absence of targets muscles, the main nerve 
branches still form, but smaller nerve branches that, in a normal limb, would lead to 
specific muscles fail to develop (Lewis et al., 1981; Phelan and Hollyday, 1990, 1991). 
These observations suggest the limb mesenchyme produces instructive cues to guide motor 
axons along different axes of the limb, but muscles as well are involved in the 
establishment of synaptic connectivity. The Eph receptor tyrosine kinases and their ephrin 
ligands form a large family of signaling molecules involved in patterning, morphogenesis 
and cell guidance in many different tissues (reviewed in (Klein, 2004; Palmer and Klein, 
2003)).  Eph and ephrins are not only expressed in motor neurons and their axon, but also 
in limb muscles, being involved in specific matching between motor axons and muscle 
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fibers (Chadaram et al., 2007; Feng et al., 2000; Lampa et al., 2004). Interestingly, Hox 
genes can regulate ephrin receptor expression in different tissues (Shaut et al., 2007; Studer 
et al., 1998). In particular, Hoxa13 has been shown to directly regulate the expression of the 
ephrin receptor EphA7 in limb mesenchymal condensations (Salsi and Zappavigna, 2006; 
Stadler et al., 2001). Our fate-map provides evidence for a differential contribution of 
Hoxa13Lin+ cells between different muscular masses but also between fibers within the 
same muscle, which could result in differential expression of Eph/ephrins. In addition, 
fibers with similar Hoxa13lin+ contribution are often clustered in the same region of the 
muscle (Fig. 8D, G #10, 14, 15, 12, 9).  As nerve-muscle connectivity occurs in determined 
regions of the muscle, clustering of muscle fibers with similar Hoxa13lin+ contribution is 
consistent with Hoxa13 being potentially involved in establishing specific synaptic 
connectivity between motor neurons and target fibers. 
 
3.5.4 Conclusion. 
Our data demonstrate that skeletal elements deriving from Hoxa13-expressing cells 
are restricted to the autopod. Yet, consistent with previous expression analysis, our study 
also points out a significant contribution of Hoxa13-expressing cells to the most proximal 
muscles of the limb thereby revealing that Hoxa13 is not a bona fide distal limb marker. 
The differential contribution of Hoxa13-expressing cells in the limb muscles is consistent 
with a potential role of Hoxa13 in muscle patterning or determination of muscle identity. 
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Moreover, differences in the distribution of Hoxa13lin+ cells within fibers of the same 
muscle suggest that Hoxa13 function could contribute to the establishment and/or 
refinement of specific neuromuscular synaptic connections. Importantly, based on the fate 
map reported here, our Hoxa13Cre line will be valuable to investigate the molecular 
signature of the various muscles and the mechanisms underlying the patterning of the limb 
musculature and the function of limb muscles.  
 
 
3.6 Materials and Methods. 
3.6.1 Targeting and generation of the Hoxa13Cre mice. 
To generate the targeting vector, a 5.2 Kb MfeI-HindIII DNA fragment containing 
Hoxa13 exon 1 and a 2.5 Kb HindIII DNA fragment containing the exon 2 were ligated and 
inserted into a modified pBluescript SK+ vector. A Cre:Ires:Venus cassette (modified from 
the Venus/PCS2 vector obtained from Atsushi Miyawaki) was inserted at the Hoxa13 ATG 
using the Recombineering technique (Copeland et al., 2001) and replaces the entire exon 1. 
The SV40 666bp sequence and neomycin cassette flanked by two Frt sites and a loxP site 
(from the PL451 plasmid obtained from N. Copeland, NCI Frederick) were added to the 3’ 
of the Cre:Ires:Venus cassette. The vector backbone was eliminated by PacI digest prior to 
electroporation into R1 ES cells. Following selection with G418, approximately 400 
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individual ES cell colonies were analyzed by Southern blot for homologous recombination. 
Two independent clones were injected into blastocysts obtained from C57BL/6J mice, 
subsequently implanted into pseudopregnant females. Germ-line transmission the 
Hoxa13Cre allele was obtained for both clones and the F1 offspring were intercrossed with 
homozygous FLPeR mice (Farley et al., 2000) to delete the neomycin cassette.  
 
3.6.2 Genotyping and mating schemes. 
Genotyping from ES cell, tail biopsies and yolk sacs was performed by Southern 
blot analysis. A scheme with restriction sites and probes used for ES cell genotyping is 
presented in Fig. 3.1. Hoxa13Cre mice were genotyped using the internal probe described 
in Fig. 1 and EcoRI digest. The Cre recombinase reporter lines were genotyped by PCR 
using the following primers: Rosa26R  (Soriano, 1999) (5’-GCG AAG AGT TTG TCC 
TCA ACC-3’; -5’GGA GCG GGA GAA ATG GAT ATG-3’; 5’-AAA GTC GCT CTG 
AGT TGT TAT-3’; wild-type 550 bp amplicon, mutant 300 bp amplicon), mT/mG 
(Muzumdar et al., 2007) (CTCTGCTGCCTCCTGGCTTCT; 
CGAGGCGGATCACAAGCAATA; TCAATGGGCGGGGGTCGTT; wild-type 330 bp 
amplicon, mutant 250 bp amplicon). For fate mapping, we crossed Hoxa13Cre/+ males 
with Rosa26R or mT/mG homozygous females and used double heterozygous embryos and 
new borns.  
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3.6.3 Whole mount in situ hybridization, X-gal staining and 
imaging.  
Whole mount in situ hybridizations were performed as previously described (Kondo 
et al., 1998a). Hoxa13 probe was previously described (Warot et al., 1997).  Whole mount 
X-gal staining was performed using standard protocols (Zakany et al., 1988). After staining, 
embryos and new born specimens were washed 3 times for one hour in PBS and stored in 
4% PFA at 4°C. All specimens were imaged using the Leica DFC320 camera. X-gal 
staining was performed on a minimum of five samples per stage. 
 
3.6.4 Immunostaining. 
Whole embryos and limbs were dissected in ice cold PBS and fixed 1-2 hrs in 4% 
PFA on ice, rinsed three times ten minutes in PBS an then placed in 30% sucrose in PBS 
overnight. Specimens were then embedded in a 1:1 mix of 30% sucrose in PBS and 
Cryomatrix (Thermo Shandon). Immunostaining for with anti Pax3 (1:250, concentrate, 
Developmental Studies Hybridoma Bank) and anti GFP antibodies (1:100, Molecular 
Probes) was performed on 12 µm cryo-sections as previously described (Relaix et al., 
2003). Immunostaining for my-32 (1:750, Sigma) was performed using the M.O.M kit 
(Vector) as in (Warot et al., 1997; Watson et al., 2009). Secondary antibodies were 
conjugated with Alexa 488 or 649 (1:500 Jackson Immunoresearch). All images were 
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captured using a ZEISS LSM710 confocal microscope. At least three sample per stage and 
10 sections per sample were analyzed.  
 
3.6.5 Muscle nomenclature. 
The nomenclature for the forelimb muscle in table 1 was derived from the Mouse 
Limb Anatomy Atlas (Delaurier et al., 2008) and from (Watson et al., 2009).  
3.7 Legends to figures.  
Figure 3.1: Generation of the Hoxa13Cre mouse line.  
(A) Hoxa13 wild type locus (top). The targeting vector is shown below and dotted 
lines indicate sequence identity of homologous arms. Targeted locus after homologous 
recombination in ES cells (middle). Position of the internal (IP) and external probes (EP), 
restriction sites and size of the DNA fragments used for Southern blot genotyping are 
indicated. Bottom: targeted locus after the FLP mediated removal of the PGK-neo selection 
cassette. (B) Southern blot analysis of ES cells clones with the external probe to detect the 
targeted allele (2), and (C) with the internal probe to confirm the absence of additional 
incorporation of the targeting construct into the genome. (D) Southern blot analysis of 
Hoxa13CreΔNeo/+ offspring after Flp recombinase mediated excision of the PGK-Neo 
cassette (2).  
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Figure 3.2: Comparison between Hoxa13 expression and 
Hoxa13lin+ cells distribution at different stages of embryonic 
development.  
Whole mount in situ hybridization of wild-type embryos with Hoxa13 probe at 
different stages of embryonic development (A, D, G, J, M, P). Whole mount X-gal staining 
of Hoxa13Cre/+; Rosa26R/+ embryos (B, C, E, F, H, I, K, L, N, O, Q, R). (B) Dotted line 
demarcates the forelimb, where, at e10, Hoxa13lin+ cells are not yet detected. (Q) X-gal 
staining of urogenital apparatus and (R, upper section) gastrointestinal tract dissected out of 
the embryo before staining.  (R, lower section) Magnification of the cecum. Arrow in (A) 
points to the forelimb. Arrowheads in A and D point to the tailbud. 
FL: forelimb, TB: tail bud, UC: umbilical cord, US: urogenital sinus, NT: neural 
tube, GT: genital tubercle, a: adrenal gland, g: gonad, k: kidney, u: urether, b: bladder, MD: 
Mullerian duct, WD: Wolffian duct, s: stomach, ce: cecum, co: colon, re: rectum.  
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Figure 3.3: Hoxa13lin+ cells in the forelimb bud and early 
forelimb are not restricted to the presumptive autopod domain.  
(A-F) Whole mount X-gal staining on Hoxa13Cre/+; Rosa26R/+ forelimbs. The 
number of somites for each embryo is reported in the bottom-left corner. (A) Hoxa13lin+ 
cells are not detected in the developing limb at 36-somite stage. After 38-somite stage, 
some positive cells are detected in the posterior and distal part of the bud, which 
progressively becomes entirely Hoxa13lin+ (B, C, D, E, F arrowheads). (D) After 45-
somite stage some Hoxa13lin+ cells are detected in the proximal region of the limb (D, E, 
F, arrows).  
 
 
Figure 3.4: Myogenic progenitors within the developing ventral 
and dorsal muscular masses of the forelimb are also Hoxa13lin+.  
(A-F) Immunostaining on Hoxa13Cre/+; mTmG forelimb bud cryosection of 47- 
(A-C) and 53- somite embryos (D-F) with anti-GFP (green signal targeted to the cell 
membrane) and anti-Pax3 (red nuclear signal). At 47-somite stage, some myogenic 
progenitors of the developing ventral and dorsal muscular masses are also Hoxa13lin+ (C, 
arrow and magnification in the dotted box). Note the increasing proportion of 
Pax3+/Hoxa13lin+ double positive cells at 53-somite stage (F, see magnification in the 
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dotted boxes). Nuclei are stained with DAPI (blue signal). d, dorsal; v, ventral. Scale bar 
140 µm.  
 
Figure 3.5: At later stages of development, the distribution of 
Hoxa13lin+ cells in the forelimb has a pattern reminiscent of the 
forming musculature. 
 (A-E) Whole mount X-gal staining on Hoxa13Cre/+; Rosa26R/+ forelimbs at 
different stages of development, dorsal view. X-gal signal is detected in muscular masses of 
the zeugopod and stylopod.  
 
Figure 3.6: The distribution of Hoxa13lin+ cells in the limb 
skeleton marks the transition between autopod and zeugopod.  
(A-C) Immunostaining on longitudinal Hoxa13Cre/+; mTmG forelimb cryosections 
at e18.5. (A-C) Sections at the autopod-zeugopod junction (autopod on the bottom) are 
shown. Hoxa13lin+ cells express the endogenous green reporter.  Myosin- positive 
muscular fibers are labeled in red. Arrowheads in A point to Hoxa13lin+ tendons in the 
autopod. (D-F) Magnification of the carpal-ulnar junction and (G-I) magnification of a 
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digit falanx in forelimb e18.5. In all panels, nuclei are stained with DAPI (blue signal). 
Scale bars 200 µm. U: ulna, R: radius, ul: ulnare, ra: radiale, i: intermedium, fa: falanx.  
 
Figure 3.7: Hoxa13lin+ contribution to muscular masses of the 
zeugopod and stylopod at e14.5. 
(A-L) Immunostaining on transversal cryosection of Hoxa13Cre/+; mTmG forelimb 
at e14.5. In all panels Hoxa13lin+ cells express the green endogenous reporter targeted to 
the cell membrane and muscles are stained with anti-myosin antibody (red signal). (A-C) 
Transversal section in the distal zeugopod. Arrowheads point to tendons, which are 
Hoxa13lin-. (D-F) transversal section in the proximal zeugopod. (G-I) Transversal section 
in the stylopod. (J-L) magnification of the boxed area in G. Numbers in B, E, H and K 
identify muscles in supplementary table 1. R: radius, U: ulna, H: humerus. Scale bar 150 
µm. a: anterior; p: posterior; d: dorsal; v; ventral.  
 
Figure 3.8: Hoxa13lin+ contribution to muscular masses of the 
zeugopod and stylopod at e18.5. 
(A-M) Immunostaining on transversal cryosection of Hoxa13Cre/+; mTmG 
forelimb at e18.5. In all panels Hoxa13lin+ cells express the green endogenous reporter 
targeted to the cell membrane and muscles are stained with anti-myosin antibody (red 
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signal). (A-C) Transversal section in the distal zeugopod. Arrowheads point to tendons, 
which are Hoxa13lin-. (D-F) Transversal section in the proximal zeugopod. (G-I) 
Transversal section in the stylopod. (J-L) magnification of the boxed area in G. Numbers in 
B, E, and H identify muscles in supplementary table 1. R: radius, U: ulna, H: humerus. 
Scale bar 360 µm. a: anterior; p: posterior; d: dorsal; v; ventral. 
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                 Table 3.1 Limb muscle nomenclature 
Muscle # Muscle name 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
 
Extensor digitorum communis 
Extensor digitorum lateralis 
Extensor pollicis 
Extensor carpi ulnaris 
Pronator quadratus 
Flexor digitorum profundis 
Flexor digitorum superficialis 
Flexor digitorum sublimis 
Supinator 
Extensor carpi radialis brevis 
Extensor carpi radialis longus 
Flexor carpi ulnaris 
Palmaris longus 
Flexor carpi radialis  
Pronator teres 
Dorsoepitrachlearis brachii 
Triceps brachii longus 
Triceps brachii lateralis 
Triceps brachii medialis  
Brachialis 
Coracobrachialis 
Biceps brachii brevis 
Biceps brachii longus 
Extensor indicis propius 
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Chapter 4: Discussion 
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4.1 Hoxa gene regulation in the extra-embryonic compartment. 
In chapter 2, we established that, in the mouse, Hoxa10, Hoxa11 and Hoxa13 are 
expressed in the allantois, a hallmark of amniote vertebrates. When these 5’ Hoxa genes are 
inactivated, embryos do not survive after e12 due to impaired development of the fetal 
vasculature within the placental labyrinth.  
We generated deletion and genomic rearrangements inside and outside the HoxA 
cluster and used transgenic approaches to gain insights into the mechanisms underlying 5’ 
Hoxa gene expression in the allantois. We found that 5’Hoxa gene expression in this 
structure relies on an enhancer-sharing mechanism and not on the specificity of the 5’ Hoxa 
promoters. We next determined that deletion of the entire HoxA cluster does not result in 
loss of expression of a reporter gene located on the 5’ of the cluster in the allantois, 
suggesting that enhancer sequence(s) located outside the cluster are sufficient to drive 
expression in this structure.  We found that the 50 kb intergenic region between Hoxa13 
and Evx1 can trigger expression of a reporter gene in the allantois. However, the deletion of 
this region does not result in loss of 5’Hoxa gene expression in the allantois, suggesting the 
existence of additional enhancer element(s).  
Altogether, our studies provide preliminary insights into Hoxa gene regulation in 
the extra-embryonic compartment, however many important questions remain to be 
addressed. 
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4.1.1 Identification of cis-regulatory elements for Hoxa genes active in the 
allantois. 
In some instances, Hox gene expression relies on local enhancers, however growing 
evidence suggests that cis-regulatory elements can be located far from their target 
promoters, as shown for Hoxd regulation in the limbs (Spitz et al., 2003; Spitz et al., 2005; 
Tschopp and Duboule, 2011). Various techniques have been employed to locate these 
regulatory sequences. Tagged BAC transgenes were used to scan the regulatory potential of 
the gene desert 5’ to the HoxD cluster. This approach was combined with sequence 
conservation analysis between different species to map the enhancer regions more 
precisely, as enhancer elements often show a higher degree of inter-species conservation 
(reviewed in (Levine, 2010)). These techniques allowed the identification of two regions 
(GCR and Prox), located respectively 180 kb and 40 kb 5’ to Hoxd13, in the gene desert. 
These regions are able to drive reporter gene expression in presumptive digits (Gonzalez et 
al., 2007; Spitz et al., 2003). While these regulatory sequences appear to be good 
candidates for the transcriptional control of Hoxd expression, the above experiments do not 
prove that Hoxd promoters are the actual targets of these regulatory elements. Moreover, it 
remains unclear whether additional enhancer elements are necessary to recapitulate the 
endogenous Hoxd gene expression in the digits.  
Recent advances in sequencing technologies and molecular techniques have helped 
in the identification of transcriptional regulatory sequences (reviewed in (Levine, 2010)). It 
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was discovered that specific histone variants and histone modifications are associated with 
active enhancers (Ong and Corces, 2011). In addition, mapping of transcriptional co-
activators binding (such as p300) was demonstrated to be a valuable tool to identify active 
enhancers (Blow et al., 2010; Visel et al., 2009). Distant enhancer-promoter interaction 
requires the formation of chromatin loops to physically trigger the association of distant 
DNA sequences within the cell nucleus (Engel and Tanimoto, 2000; Sexton et al., 2009). 
Various techniques have been recently developed to identify these contacts. For example, 
chromosome conformation capture (3C)- based techniques can be used to determine the 
interaction frequency of a specific promoter with regulatory regions located on the same 
chromosome, or even on different chromosomes (Gavrilov et al., 2009). Thus, the 
combined analysis of chromatin marks and chromatin conformation can be instrumental to 
identify enhancers active at different genomic loci.  
Very recently, work from the Duboule lab has demonstrated that these techniques 
are valid tools to identify limb enhancers for Hoxd genes (Montavon et al., 2011). Using 
3C, Montavon and collaborators confirmed for the first time the physical interaction in vivo 
between previously identified limb enhancers (GCR and Prox) and 5’Hoxd gene promoters. 
Moreover, analysis by chromosome conformation capture in the limb suggested the 
presence of additional limb enhancers located in a more remote location in the gene desert 
located on the centromeric side of the HoxD cluster. The further characterization of 
chromatin marks associated with active enhancers was used to verify that these sequences 
are likely limb enhancers.  Transgenic analysis confirmed that some of these sequences are 
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able to drive expression of a reporter transgene in the limb. However, other elements cannot 
activate reporter transcription by themselves, and are probably required at the structural 
level, to generate a specific 3D chromatin conformation suitable for transcription. In fact, 
enhancer-promoter interaction, in some instances, may not be mediated by a single and 
direct chromatin loop, but could require a more complex 3D conformation, which would be 
favoured by the contacts of enhancers and promoter with other DNA sequences.  Only the 
deletion of the entire 800 kb gene desert containing all these cis-regulatory elements results 
in the complete abrogation of 5’ Hoxd genes in the limb (Montavon et al., 2011). 
Altogether, these data suggest that regulatory landscapes underlying Hox gene expression 
in embryonic tissues can be extremely complex, containing multiple and redundant 
enhancers active in the same tissues, some of which are very distant from the target gene 
promoters. Thus, the presence of multiple sequences driving expression of the same genes 
in a determined tissue could confer robustness to the system, making the expression of 
these genes particularly resilient to genetic mutations.  
We have previously shown that the 50 kb intergenic region between Hoxa13 and 
Evx1 is able to drive reporter expression in the allantois. Our results, however, also 
demonstrate that other sequences are involved in 5’ Hoxa gene regulation in this tissue. To 
identify these other cis-regulatory elements, a similar approach, as previously employed to 
locate enhancers of 5’Hoxd gene in the limb, could be used. 3C-based experiments 
combined with analysis of chromatin marks associated with active enhancers could be 
performed on allantois DNA. Chromatin marks associated with active enhancers and 
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binding sites for transcription co-activators, such as p300, could be measured using 
Chromatin Immunoprecipitation (ChIP), followed by high-throughput sequencing (ChIP-
seq), in order to precisely map these regions (Park, 2009). Candidate regions could be 
subsequently tested by 3C for contacts with 5’Hoxa gene promoters. DNA sequences 
identified with these two techniques can be further tested by classical transgenesis. This 
unbiased approach will help to determine the position of other allantois enhancers, even if 
they are at a large distance in the chromosome. As in the case of the limbs, it is possible 
that some elements will be able to drive reporter gene expression in the allantois, while 
other sequences will be required to mediate the interaction of enhancers with target gene 
promoters, generating a specific 3D chromatin conformation suitable for transcription. It 
was previously shown that limb enhancers do not only contact Hoxd gene promoters, but 
also establish mutual interactions (Gonzalez et al., 2007; Montavon et al., 2011). To test 
whether a specific DNA element is essential in the allantois to maintain a 3D chromatin 
conformation permitting enhancer-promoter interactions, the sequential deletion of each 
previously identified region could be performed. Alternatively, as is the case for Hoxd 
genes in the limbs, it may be that only the deletion of the entire set of enhancers will result 
in the complete loss of 5’Hoxa gene expression in the allantois, suggesting that these 
regulatory elements are functionally redundant. Moreover, the establishment of the precise 
location of 5’Hoxa gene enhancer sequences in the allantois would also be crucial to predict 
binding sites for upstream regulators for 5’Hoxa genes.  
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4.1.2 Loss of enhancer activity upon fragmentation of the IR50 transgene.  
We have previously shown that the 50 kb intergenic region between Hoxa13 and 
Evx1 is able to drive reporter gene expression in the allantois. In an attempt to map more 
precisely the DNA sequence responsible for this activity, we subcloned the 50 kb fragment 
(IR50) into twelve smaller DNA regions and tested whether any of these smaller fragments 
could drive reporter gene expression in the allantois. Interestingly, none of the smaller 
transgenes was able to drive reporter gene expression in the allantois in our assay. Several 
possibilities could account for this result. As previously mentioned, enhancer elements are 
often, but not always, conserved among species. Thus, our experimental design, even if 
preserved the integrity of conservation sequences, could have simply led to the split of the 
enhancer(s) element(s) between two different transgenes. Alternatively, it is possible that 
the inability to trigger expression using our transgenic approach reflects an important role 
of the 3D organization of the Hoxa13-Evx1 intergenic region in transcriptional control. In 
fact, it is possible that different regions within the IR50 fragment need to physically interact 
in order to trigger expression of the reporter in the allantois. In this view, the synergism 
between two or more regions, any of which are unable, alone, to activate transcription, 
would be required to activate 5’Hoxa gene expression. Thus analysis of the DNA-DNA 
contacts in allantois cells between 5’Hoxa gene promoters and the 50 kb intergenic region 
will be instrumental to identify the putative enhancer(s). The candidate sequences could be 
further tested in transgenic assays to determine whether they can drive expression of a 
reporter gene. The identified regions could be tested in transgenic assays on their own, or 
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two or more identified regions could be combined together in the same transgene, to test if 
the interaction among these different elements is required for transcription. 
 
We have shown that the Hoxa13-Evx1 intergenic region is also able to drive reporter 
gene expression in the trunk (Fig. S 2.6). However, none of the smaller transgenes we 
generated was able to recapitulate this expression pattern, raising the possibility that the 
expression pattern in both trunk and in allantois could rely on the same regulatory 
sequences. Thus, the expression of 5’Hoxa genes in the allantois could be the result of the 
subsequent functional co-option of the trunk enhancer, and not associated to the appearance 
of a novel cis-regulatory element. However, differences in 5’ Hoxa gene activation in trunk 
and allantois would suggest that 5’ Hoxa gene transcription relies on different mechanisms 
in these two regions. First, our genetic fate-mapping analysis of Hoxa13-expressing cells 
showed that only a subpopulation of mesenchymal cells of the allantois starts expressing 
Hoxa13, in contrast to the trunk. Furthermore, in the trunk, Hoxa genes are progressively 
activated in a sequential manner, Hoxa1 being the first to be expressed and Hoxa13 the last. 
In contrast, in the allantois, Hoxa1 to Hoxa9 are never expressed, and we coulnd’t detect 
any differences in the timing of activation of Hoxa10, Hoxa11 and Hoxa13.  
To determine whether the expression of 5’Hoxa genes in the allantois was generated 
by co-option of trunk enhancer(s) or by evolutionarily novel regulatory elements, the DNA-
DNA contacts established by 5’Hoxa gene promoters with DNA sequences within the 50 
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kb intergenic region in both allantois and trunk tissue could be determined. This analysis, 
combined with transgenic assays, will indicate whether the same region(s) within the 50 kb 
intergenic fragment contact 5’Hoxa gene promoters in both tissues or not.  
4.1.3 Hoxa gene expression in the allantois is restricted to 5’Hoxa genes. 
Another interesting question concerns the mechanisms by which Hoxa gene 
expression in the allantois is restricted to Hoxa10, Hoxa11, and Hoxa13. Our experiments 
suggest the presence of long distance enhancer element(s) necessary for 5’Hoxa gene 
expression in the allantois. However, the action of this/these enhancer(s) is specifically 
targeted to 5’Hoxa gene promoters, while the adjacent Hoxa9 gene, as well as other 3’Hoxa 
genes, are not expressed in the allantois. It would be of interest to determine how this 
interaction between remote enhancer(s) is selectively restricted to this subset of Hoxa genes 
of the cluster. Interestingly, Hoxa gene expression in presumptive digits is also restricted to 
Hoxa10, Hoxa11 and Hoxa13 and involves an enhancer sharing mechanism. In fact, a 
reporter targeted to the 5’ of Hoxa13 is also expressed in the digits (not shown). Previous 
studies suggested that the regulation of 5’Hoxa genes in the limbs also relies on distant 
enhancers located on the 5’ of Hoxa13 (Lehoczky and Innis, 2008). We also found that the 
deletion of the 50 kb Hoxa13-Evx1 intergenic region does not result in loss of 5’Hoxa gene 
expression in the limbs (not shown) suggesting that digit enhancer(s) are located at a 
remote position. Yet, only a subset of Hoxa genes is activated by this/these enhancer(s). 
One possibility is that an insulator element is involved in generating a transcription 
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boundary between Hoxa9 and Hoxa10. Insulators are DNA sequences that preclude 
interaction between two DNA domains. Two different types of insulators have been 
identified. The first are enhancer-blocking insulators, which protect from activation by 
enhancers. Secondly, barrier insulators are involved in protecting DNA regions from 
heterochromatin-mediated silencing, and may be required to maintain heterochromatin 
organization (reviewed in (Gaszner and Felsenfeld, 2006)). The existence of both types of 
insulator elements has been described at the β-globin locus (Chung et al., 1993; Hebbes et 
al., 1994). Moreover, the presence of insulator sequences has been reported within the 
Drosophila Hox cluster (Akbari et al., 2006), and targeted rearrangements within mouse 
Hox clusters suggest that these sequences are also likely to be involved in the regulation of 
Hox gene expression in vertebrates (Kmita et al., 2000a; Kmita et al., 2002b).  
Another possibility is that the exclusive expression of 5’ Hoxa genes relies on the 
presence of promoter-proximal tethering elements in the vicinity of Hoxa10, Hoxa11 and 
Hoxa13 promoter (s). These elements have been identified in Drosophila and are required 
to mediate specific promoter-enhancer interaction within the Antennapedia complex 
(Calhoun et al., 2002; Ho et al., 2011), however, the presence of promoter-proximal 
tethering elements in vertebrate genomes has not yet been demonstrated.  
To gather insights into the mechanism leading to the exclusive activation of specific 
5’Hoxa genes in the allantois and in the limb, different deletions within the HoxA cluster 
could be generated, in order to delete putative insulators or promoter-proximal tethering 
elements. For example, if the deletion of the Hoxa10-Hoxa13 region leads to the ectopic 
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activation of Hoxa9, it would suggest that promoter-proximal tethering elements are present 
in the Hoxa10-Hoxa13 DNA fragment. If this deletion does not cause ectopic expression of 
Hoxa9, it would be more likely that an insulator element is located in the intergenic region 
between Hoxa10 and Hoxa9. This last hypothesis could be challenged by generating a 
targeted deletion of the Hoxa9-Hoxa10 intergenic region and by testing whether this 
configuration results in ectopic expression of 3’Hoxa genes. Interestingly, a highly 
conserved DNA fragment is present just upstream of Hoxa10, and could be a good 
candidate insulator element. Preliminary experiments to test the ability of this DNA 
sequence to block enhancer activity could be performed in vitro as in (Lunyak et al., 2007) 
4.1.4 Conclusion. 
Altogether, the results presented in this thesis demonstrate that 5’Hoxa gene 
function in the allantois is required for embryonic survival. Moreover, we found that the 
regulatory mechanism underlying the expression of these genes in the extra-embryonic 
compartment is complex, suggesting that multiple cis-regulatory sequences are at work. 
Combined sequencing technologies and molecular techniques will be helpful to gain further 
understanding of 5’Hoxa gene transcriptional regulation in the allantois. Moreover, the 
generation of different deletions and rearrangements within the HoxA locus will allow a 
better understanding of Hoxa gene transcriptional control in the allantois and in other 
tissues/organs.  
  
 
159 
4.2 Hoxa gene function in the muscles. 
In chapter 2, we showed that Hoxa13 function in the extra-embryonic compartment 
is required for the proper development of foetal vasculature in the placental labyrinth. Our 
gene expression studies however, demonstrate that Hoxa13 expression occurs transiently in 
the allantois, the structure from which the labyrinthine vasculature originates, and is not 
maintained in the labyrinth. In some instances therefore, Hoxa13 function is important in 
domains in which its expression is not detected. Genetic fate-mapping experiments allow us 
to establish the ultimate fate of cells that express a gene of interest. Mapping all the organs 
and structures that originate from these cells is highly informative with respect to gene 
function. In chapter 3, to better characterize the role of Hoxa13 and to identify potential 
novel aspects of its function, we generated a new Hoxa13 allele to permanently label 
Hoxa13-expressing cells and their descendants (referred to as Hoxa13lin+). In the 
developing limbs, our lineage-tracing experiment demonstrated that Hoxa13lin+ cells 
contribute to all structures of the autopod. Moreover Hoxa13lin+ cells give rise to a specific 
subset of limb muscles within the zeugopod and stylopod, where they form muscular fibers. 
We found that Hoxa13 expressing cells and their descendants are not equally distributed 
among the different muscular masses. Within a given muscle, fibers with similar 
Hoxa13lin+ cells contribution often cluster together. Altogether, our data and previous 
expression analyses suggest a function for Hoxa13 in the determination of muscle identity 
and/or in the biology of these muscles.  
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4.2.1 The Hoxa13Cre line is a tool to explore molecular identities of limb 
muscles. 
Molecular differences have been identified among skeletal muscles committed to 
different tasks (Porter et al., 2001). However, whether muscles within the same anatomical 
structure, such as the limb, are characterized by an identical molecular profile remains 
unknown. Interestingly, we found that Hoxa13lin+ contribution to the different muscular 
masses of the limb is not the same, and muscles characterized by high GFP fluorescence 
emanating from the Cre reporter allele and muscle almost or completely deprived of GFP+ 
fibers can be distinguished. Thus, our Hoxa13Cre line could be a valuable tool to explore 
potential molecular differences between muscles characterized by different Hoxa13lin+ 
contributions. Specifically, GFP positive and negative fibers in each muscle could be easily 
separated using fluorescent activated-cell sorting from Hoxa13Cre/+; mT/mG animals. 
Subsequent expression profiling of the GFP+ population of one muscle could be compared 
to the GFP- of the other muscle using the RNA-seq technique to reveal differences in gene 
expression between the two cell populations (Wang et al., 2009). Moreover, the differential 
contribution of Hoxa13lin+ cells to the limb muscles raises the possibility that Hoxa13 
could be involved in establishing specific features of different muscles groups. To 
determine whether potential molecular differences between these two cell populations are a 
result of Hoxa13 expression, the expression profile of the GFP+ population in 
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Hoxa13Cre/+; mT/mG could be compared to the GFP+ population of mice lacking Hoxa13 
function (Hoxa13Cre/HoxaAflox; mT/mG mutants, see next paragraph). This comparison 
could also help identify putative Hoxa13 target genes in muscle.  
 
Our genetic fate mapping in limbs demonstrated that Hoxa13lin+ cells differentially 
contribute to muscular fibers, in which differences in the Cre reporter GFP fluorescence can 
be detected. This heterogeneity could be explained either by a variable proportion of 
Hoxa13lin+/Hoxa13lin- myoblasts that fuse together to generate fibers, or by differences in 
the subsequent expression of Hoxa13 after the fiber is formed. In the first case, the 
contribution of Hoxa13lin+ cells to the musculature would be established before myoblast 
fusion, while in the second case Hoxa13 would also be expressed after fusion. To test these 
two hypotheses, a genetic approach could be used. The fusion of Hoxa13lin+ myoblasts 
could be blocked through the conditional inactivation of the small G-protein Rac1, which is 
essential for myoblast fusion in the mouse (Vasyutina et al., 2009). For this purpose, 
Hoxa13Cre/+; Rac1flox/flox; mT/mG embryos could be generated. In this mutant context, 
the fate of Hoxa13lin+ cells could be easily monitored using the Cre fluorescent reporter. 
Two scenarios are possible. In the first case, the Hoxa13lin+/GFP+ cell population could 
give rise only to mononucleated fibers, while multinucleated fibers will be mainly 
Hoxa13lin-/GFP-. This result would suggest that Hoxa13 is only activated in myogenic 
progenitors before they fuse into the fiber, and Hoxa13lin- cells do not express Hoxa13 
after fusion. In contrast, if a significant percentage of multinucleated cells is 
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Hoxa13lin+/GFP+ it would indicate that, in these nuclei, Hoxa13 activation occurred after 
myoblast fusion. In this case, the final Hoxa13lin+ contribution to each fiber would be 
established only at later stages.  
4.2.2 The Hoxa13Cre line is a tool to explore Hoxa13 function in limb 
muscles at later stages of development. 
Hoxa13 homozygous mutants are embryonic lethal and do not survive after e15, 
precluding the analysis of potential mutant phenotypes in limb muscles at later stages of 
embryonic development and in adults. Our Hoxa13Cre allele is also a loss of function of 
Hoxa13 due to the targeting of the Cre coding sequence at the first exon of the Hoxa13 
gene. Thus, in Hoxa13Cre/HoxAflox mutants, Hoxa13 inactivation occurs in all cells that 
normally express Hoxa13. However, the time required for Cre mediated deletion of the 
HoxA cluster generates a slight delay in Hoxa13 inactivation. This delay is sufficient to 
rescue the placental phenotype associated with Hoxa13 loss-of-function, and 
Hoxa13Cre/HoxAflox mutants are fully viable and display a vasculature within the 
labyrinth comparable to wild-type specimens (Scotti and Kmita, 2012). However, these 
mice exhibit limb defects reminiscent of the phenotype associated with complete Hoxa13 
inactivation, including absence of digit 1, shortening and malformation of the other digits 
and fusion of the interdigital tissue (Fig. 2.5 in chapter 2). In fact, Hoxa13 expression in the 
extra-embryonic tissues is only transient, while it is detected in the limbs over several days. 
Thus, Hoxa13Cre/HoxAflox mutant can be used to explore the role of Hoxa13 at later 
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stages of development and may be a useful tool to investigate Hoxa13 function in the limb 
muscles. Moreover, our lineage fate-mapping analysis demonstrated that in the zeugopod 
and stylopod, Hoxa13 expressing cells and their descendants only give rise to the muscles 
and not to skeletal elements. Thus, potential defects observed in the zeugopod and stylopod 
muscles of Hoxa13Cre/HoxAflox mutants would be a direct consequence of Hoxa13 loss-
of-function in this tissue, and not a secondary effect of Hoxa13 inactivation in the skeleton. 
 
In the mouse limb, the process of muscle formation starts soon after the onset of 
somitogenesis and continues after birth, throughout the entire life of the animal (reviewed 
in (Murphy and Kardon, 2011)). During muscle development, different phases of 
myogenesis can be identified (reviewed in (Biressi et al., 2007; Murphy and Kardon, 
2011)). During embryonic myogenesis, which in the limbs begins around e10.5, the 
establishment of the basic muscular pattern takes place. Later on, during fetal and neonatal 
myogenesis (from e14.5 to P0 and from P0 to P21 respectively) muscles undergo a process 
of growth and maturation. Adult myogenesis promotes growth and repair of the damaged 
muscle tissue. During embryogenesis, primary fibers form from the fusion of embryonic 
myoblasts, and secondary fibers from fetal myoblasts (Kelly and Zacks, 1969). In the adult, 
muscle fibers can be classified on be basis of their speed of contraction (Wigmore and 
Evans, 2002).  
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Preliminary analysis performed on e14.5 Hoxa13-/- mutants reported the presence 
of defects in both shape and size of a subset of limb muscles, such as the flexor carpi 
radialis, the peroneus longus and brevis and the quadratus plantae (Yamamoto and 
Kuroiwa, 2003). However, analyses at later stages have been precluded by the embryonic 
lethality associated with Hoxa13 inactivation. Expression analyses demonstrated that 
Hoxa13 mRNA is still detectable in the limb muscles after e14.5 and in the adult tissue 
(Perez et al., 2010; Yamamoto and Kuroiwa, 2003). Thus, it is possible that Hoxa13 
function is required at later stages of muscle development for growth of the muscular 
masses and/or the determination of final morphology. To investigate this aspect, it would 
be of interest to perform analysis of Hoxa13Cre/HoxAflox limb muscles at late 
developmental stages, as many defects would be detectable only after e14.5. For this 
purpose, classical histology and immunohistochemistry on sections could be used to 
visualize muscular masses and to determine their size, organization and relative positions 
(Watson et al., 2009). Moreover, the different muscular masses could be analyzed for their 
fiber number and identity (primary/secondary, fast and slow), and the size of the fibers 
could be assessed.  In fact, Hoxa13 function could be required during embryonic or fetal 
myogenesis to form primary or secondary fibers respectively. In that case, the ratio between 
the primary and secondary fibers would be affected in Hoxa13Cre/HoxAflox mutants. An 
overall reduction in fiber number, without modification in the proportion of primary and 
secondary fibers, would suggest that Hoxa13 function is required at both stages of 
myogenic differentiation.  
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After birth, the neonatal and adult muscle progenitors are mononucleated cells 
located between the cell membrane and the basal lamina of adult myofibers and are thus 
named satellite cells (Mauro, 1961). These cells proliferate and differentiate into myoblasts 
to complete the postnatal myogenic process and are reactivated in response to injury or 
damage to achieve muscle repair (Charge and Rudnicki, 2004). Previous in vitro 
experiments demonstrated that Hoxa13 overexpression is able to downregulate the levels of 
the myogenic transcription factor MyoD in myoblast cells (Yamamoto and Kuroiwa, 2003). 
Thus, these results suggest that Hoxa13 could be involved in the repression of MyoD and 
the myogenic differentiation program of a subset of muscle progenitors. It would be of 
interest to determine if satellite cells are also part of Hoxa13lin+ cell population. If this is 
the case, it could be established whether Hoxa13 loss of function alters the number and/or 
the characteristics of satellite cells during normal postnatal muscle growth or after injury.  
 
Neuromuscular junctions (NMJs) are synapses between motor neurons and the 
motor end plate. These form in specific region of the muscle, and expression of muscle-
derived factors in these regions before innervation is essential for NMJ formation 
(neuromuscular pre-patterning) (Lin et al., 2001; Yang et al., 2001). Synapses form in 
excess and subsequently undergo refinement, in which supernumerary synapses are 
eliminated (Favero et al., 2009; Redfern, 1970). Hoxa13lin+ cells differentially contribute 
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to the various fibers within a specific muscle, and fibers characterized by similar GFP 
fluorescence are often clustered in the same region of the muscle. Thus, it is possible that 
Hoxa13 could be involved in the establishment of neuromuscular connectivity, by 
controlling the expression of muscle-derived factors important for muscle pre-patterning in 
specific region of the muscle. To determine if Hoxa13 function plays a role in muscle pre-
patterning and/or NMJ formation or refinement, Hoxa13Cre/HoxAflox animals could be 
analyzed at different stages of development. At e14.5, before neuromuscular connections 
are established, the distribution of acetylcholine receptor and muscle-specific kinase, 
proteins involved in the neuromuscular pre-patterning process, can be tested by whole 
mount immunostaining (Chen et al., 2011). At later stages, the number, position, shape and 
functionality of the neuromuscular junctions could be assessed using immunostaining and 
electrophysiology techniques on dissected muscles (Chen et al., 2011; Noakes et al., 1995).  
4.2.3 Hoxa gene function in muscle development. 
 The analyses of Hoxa13Cre/HoxAflox mutants will be informative to determine 
whether Hoxa13 inactivation is associated with muscular defects. However, in many 
instances, the function of a specific Hox gene in a determined tissue cannot be assessed by 
the analysis of single loss-of-function allele because of functional redundancy among 
various Hox genes (see e.g. (Davis and Capecchi, 1996; Fromental-Ramain et al., 1996a; 
Fromental-Ramain et al., 1996b; Wellik and Capecchi, 2003)). In fact, the function of 
paralogous and/or non-paralogous genes in the same tissue can, in many cases, compensate 
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for the inactivation of the gene of interest. Thus, the simultaneous inactivation of more than 
one paralogous gene, or of different genes of the same cluster, can result in the appearance 
of novel mutant phenotypes, which are not present in single gene loss-of-function 
phenotype (Di-Poi et al., 2010a; Magnusson et al., 2007; Warot et al., 1997).  
The expression of other Hoxa genes has been previously reported in limb muscles 
(Benson et al., 1995; Haack and Gruss, 1993; Houghton and Rosenthal, 1999; Yamamoto et 
al., 1998) raising the possibility that other Hoxa genes could be functional in this tissue. To 
assess their overall role in developing and adult muscles, Hoxa genes could be 
conditionally inactivated in all myogenic progenitors of the limb. The conditional 
inactivation could be achieved using a the HoxAflox allele and the Pax3Cre or Lbx1Cre 
deleter strains, which are expressed in all muscle progenitors of the body or all migrating 
myogenic cells in limb, tongue and diaphragm respectively (Engleka et al., 2005; Vasyutina 
et al., 2007). The limb muscles of HoxAflox/flox; Pax3Cre or HoxAflox/flox; Lbx1Cre 
embryos and mice could be analyzed at different stages of development as previously 
described for Hoxa13Cre/HoxAflox mutants.  
 
In many instances, functional redundancy and synergism exist between Hoxd and 
Hoxa genes in developing limbs, and the inactivation of both clusters results in a limb 
phenotype much more severe than single cluster inactivation (Kmita et al., 2005). 
Moreover, preliminary results from Ashby and collaborators suggest that Hoxd genes are 
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also expressed in the developing limb muscles and HoxD-/- mutants present patterning 
defects in a subset of limb muscles (Ashby et al., 2002). Thus, the analysis of limb muscles 
from Hoxa13Cre/HoxAflox; HoxD-/- and HoxAflox/flox; Pax3Cre; HoxD-/- mutants could 
uncover novel phenotypes, or exacerbate defects already existent in single cluster 
inactivation.  
4.2.4 Conclusion. 
 Altogether, our lineage fate-mapping experiments and previous expression analysis 
suggest that Hoxa13 might be functional during limb muscle development. Importantly, the 
genetic tool we generated allow us to overcome the embryonic lethality associated to 
Hoxa13 inactivation, and will be instrumental to explore Hoxa13 function at later stages of 
muscle development. Moreover, our data provide support to previous evidence suggesting 
that Hoxa and Hoxd function during limb development might not be confined solely to the 
skeletal compartment. The analysis of Hox conditional inactivation in the different limb 
tissues will be critical in understanding the different roles of these genes in bone and 
muscle development.  
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